Loading...
Sign in to edit your profile (add interests, overview, photo, etc.)

    Jagust, William

    TitleMedical Scientist Sr Faculty
    SchoolLawrence Berkeley National Lab
    DepartmentMolecular Biophys & Integ Bio
    Address1 Cyclotron Road
    Berkeley CA 94720
    Phone510/486-5065
    vCardDownload vCard

      Collapse Bibliographic 
      Collapse Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. Berry AS, Shah VD, Furman DJ, White RL, Baker SL, O'Neil JP, Janabi M, D'Esposito M, Jagust W. Dopamine Synthesis Capacity is Associated with D2/3 Receptor Binding but not Dopamine Release. Neuropsychopharmacology. 2017 Aug 17. PMID: 28816243.
        View in: PubMed
      2. Maass A, Landau S, Baker SL, Horng A, Lockhart SN, Joie R, Rabinovici GD, Jagust W. Comparison of multiple tau-PET measures as biomarkers in aging and Alzheimer's Disease. Neuroimage. 2017 Jun 03. PMID: 28587897.
        View in: PubMed
      3. Schreiber S, Schreiber F, Lockhart SN, Horng A, Bejanin A, Landau SM, Jagust W. Alzheimer Disease Signature Neurodegeneration and APOE Genotype in Mild Cognitive Impairment With Suspected Non-Alzheimer Disease Pathophysiology. JAMA Neurol. 2017 Jun 01; 74(6):650-659. PMID: 28319241.
        View in: PubMed
      4. Insel PS, Ossenkoppele R, Gessert D, Jagust W, Landau S, Hansson O, Weiner MW, Mattsson N. Time to Amyloid Positivity and Preclinical Changes in Brain Metabolism, Atrophy, and Cognition: Evidence for Emerging Amyloid Pathology in Alzheimer's Disease. Front Neurosci. 2017; 11:281. PMID: 28567001.
        View in: PubMed
      5. Tosun D, Landau S, Aisen PS, Petersen RC, Mintun M, Jagust W, Weiner MW. Association between tau deposition and antecedent amyloid-ß accumulation rates in normal and early symptomatic individuals. Brain. 2017 Mar 17. PMID: 28334939.
        View in: PubMed
      6. Lockhart SN, Schöll M, Baker SL, Ayakta N, Swinnerton KN, Bell RK, Mellinger TJ, Shah VD, O'Neil JP, Janabi M, Jagust W. Amyloid and tau PET demonstrate region-specific associations in normal older people. Neuroimage. 2017 Apr 15; 150:191-199. PMID: 28232190.
        View in: PubMed
      7. Marks SM, Lockhart SN, Baker SL, Jagust W. Tau and ß-Amyloid Are Associated with Medial Temporal Lobe Structure, Function, and Memory Encoding in Normal Aging. J Neurosci. 2017 Mar 22; 37(12):3192-3201. PMID: 28213439.
        View in: PubMed
      8. Lockhart SN, Ayakta N, Winer JR, La Joie R, Rabinovici GD, Jagust W. Elevated 18F-AV-1451 PET tracer uptake detected in incidental imaging findings. Neurology. 2017 Mar 14; 88(11):1095-1097. PMID: 28188303.
        View in: PubMed
      9. Leal SL, Landau SM, Bell RK, Jagust W. Hippocampal activation is associated with longitudinal amyloid accumulation and cognitive decline. Elife. 2017 Feb 08; 6. PMID: 28177283.
        View in: PubMed
      10. Spina S, Schonhaut DR, Boeve BF, Seeley WW, Ossenkoppele R, O'Neil JP, Lazaris A, Rosen HJ, Boxer AL, Perry DC, Miller BL, Dickson DW, Parisi JE, Jagust W, Murray ME, Rabinovici GD. Frontotemporal dementia with the V337M MAPT mutation: Tau-PET and pathology correlations. Neurology. 2017 Feb 21; 88(8):758-766. PMID: 28130473.
        View in: PubMed
      11. Liu CY, Ohki Y, Tomita T, Osawa S, Reed BR, Jagust W, Van Berlo V, Jin LW, Chui HC, Coppola G, Ringman JM. Two Novel Mutations in the First Transmembrane Domain of Presenilin1 Cause Young-Onset Alzheimer's Disease. J Alzheimers Dis. 2017; 58(4):1035-1041. PMID: 28550247.
        View in: PubMed
      12. Seo SW, Ayakta N, Grinberg LT, Villeneuve S, Lehmann M, Reed B, DeCarli C, Miller BL, Rosen HJ, Boxer AL, O'Neil JP, Jin LW, Seeley WW, Jagust W, Rabinovici GD. Regional correlations between [11C]PIB PET and post-mortem burden of amyloid-beta pathology in a diverse neuropathological cohort. Neuroimage Clin. 2017; 13:130-137. PMID: 27981028.
        View in: PubMed
      13. Yassine HN, Feng Q, Azizkhanian I, Rawat V, Castor K, Fonteh AN, Harrington MG, Zheng L, Reed BR, DeCarli C, Jagust W, Chui HC. Association of Serum Docosahexaenoic Acid With Cerebral Amyloidosis. JAMA Neurol. 2016 Oct 01; 73(10):1208-1216. PMID: 27532692.
        View in: PubMed
      14. Baker SL, Lockhart SN, Price JC, He M, Huesman RH, Schonhaut D, Faria J, Rabinovici G, Jagust W. Reference Tissue-Based Kinetic Evaluation of 18F-AV-1451 for Tau Imaging. J Nucl Med. 2017 Feb; 58(2):332-338. PMID: 27587706.
        View in: PubMed
      15. Jagust W. Tau and ß-Amyloid-The Malignant Duo. JAMA Neurol. 2016 Sep 01; 73(9):1049-50. PMID: 27454015.
        View in: PubMed
      16. Babiloni C, Del Percio C, Caroli A, Salvatore E, Nicolai E, Marzano N, Lizio R, Cavedo E, Landau S, Chen K, Jagust W, Reiman E, Tedeschi G, Montella P, De Stefano M, Gesualdo L, Frisoni GB, Soricelli A. Cortical sources of resting state EEG rhythms are related to brain hypometabolism in subjects with Alzheimer's disease: an EEG-PET study. Neurobiol Aging. 2016 Dec; 48:122-134. PMID: 27668356.
        View in: PubMed
      17. Tosun D, Schuff N, Rabinovici GD, Ayakta N, Miller BL, Jagust W, Kramer J, Weiner MM, Rosen HJ. Diagnostic utility of ASL-MRI and FDG-PET in the behavioral variant of FTD and AD. Ann Clin Transl Neurol. 2016 Oct; 3(10):740-751. PMID: 27752510.
        View in: PubMed
      18. Jagust W. Early life sets the stage for aging. Proc Natl Acad Sci U S A. 2016 Aug 16; 113(33):9148-50. PMID: 27436907; PMCID: PMC4995968 [Available on 02/16/17].
      19. Chételat G, Ossenkoppele R, Villemagne VL, Perrotin A, Landeau B, Mézenge F, Jagust W, Dore V, Miller BL, Egret S, Seeley WW, van der Flier WM, La Joie R, Ames D, van Berckel BN, Scheltens P, Barkhof F, Rowe CC, Masters CL, de La Sayette V, Bouwman F, Rabinovici GD. Atrophy, hypometabolism and clinical trajectories in patients with amyloid-negative Alzheimer's disease. Brain. 2016 Sep; 139(Pt 9):2528-39. PMID: 27357349.
        View in: PubMed
      20. Lockhart SN, Baker SL, Okamura N, Furukawa K, Ishiki A, Furumoto S, Tashiro M, Yanai K, Arai H, Kudo Y, Harada R, Tomita N, Hiraoka K, Watanuki S, Jagust W. Dynamic PET Measures of Tau Accumulation in Cognitively Normal Older Adults and Alzheimer's Disease Patients Measured Using [18F] THK-5351. PLoS One. 2016; 11(6):e0158460. PMID: 27355840; PMCID: PMC4927104.
      21. Mander BA, Winer JR, Jagust W, Walker MP. Sleep: A Novel Mechanistic Pathway, Biomarker, and Treatment Target in the Pathology of Alzheimer's Disease? Trends Neurosci. 2016 Aug; 39(8):552-66. PMID: 27325209; PMCID: PMC4967375 [Available on 08/01/17].
      22. Risacher SL, McDonald BC, Tallman EF, West JD, Farlow MR, Unverzagt FW, Gao S, Boustani M, Crane PK, Petersen RC, Jack CR, Jagust W, Aisen PS, Weiner MW, Saykin AJ. Association Between Anticholinergic Medication Use and Cognition, Brain Metabolism, and Brain Atrophy in Cognitively Normal Older Adults. JAMA Neurol. 2016 Jun 01; 73(6):721-32. PMID: 27088965.
        View in: PubMed
      23. Oh H, Madison C, Baker S, Rabinovici G, Jagust W. Dynamic relationships between age, amyloid-ß deposition, and glucose metabolism link to the regional vulnerability to Alzheimer's disease. Brain. 2016 Aug; 139(Pt 8):2275-89. PMID: 27190008; PMCID: PMC4958895 [Available on 08/01/17].
      24. Insel PS, Mattsson N, Mackin RS, Schöll M, Nosheny RL, Tosun D, Donohue MC, Aisen PS, Jagust W, Weiner MW. Accelerating rates of cognitive decline and imaging markers associated with ß-amyloid pathology. Neurology. 2016 May 17; 86(20):1887-96. PMID: 27164667; PMCID: PMC4873684 [Available on 05/17/17].
      25. Landau SM, Horng A, Fero A, Jagust W. Amyloid negativity in patients with clinically diagnosed Alzheimer disease and MCI. Neurology. 2016 Apr 12; 86(15):1377-85. PMID: 26968515; PMCID: PMC4831042 [Available on 04/12/17].
      26. Ossenkoppele R, Schonhaut DR, Schöll M, Lockhart SN, Ayakta N, Baker SL, O'Neil JP, Janabi M, Lazaris A, Cantwell A, Vogel J, Santos M, Miller ZA, Bettcher BM, Vossel KA, Kramer JH, Gorno-Tempini ML, Miller BL, Jagust W, Rabinovici GD. Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer's disease. Brain. 2016 May; 139(Pt 5):1551-67. PMID: 26962052; PMCID: PMC5006248 [Available on 05/01/17].
      27. Fletcher E, Villeneuve S, Maillard P, Harvey D, Reed B, Jagust W, DeCarli C. ß-amyloid, hippocampal atrophy and their relation to longitudinal brain change in cognitively normal individuals. Neurobiol Aging. 2016 Apr; 40:173-80. PMID: 26973117; PMCID: PMC4792128 [Available on 04/01/17].
      28. Schreiber S, Vogel J, Schwimmer HD, Marks SM, Schreiber F, Jagust W. Impact of lifestyle dimensions on brain pathology and cognition. Neurobiol Aging. 2016 Apr; 40:164-72. PMID: 26973116; PMCID: PMC4792130 [Available on 04/01/17].
      29. Jack CR, Knopman DS, Chételat G, Dickson D, Fagan AM, Frisoni GB, Jagust W, Mormino EC, Petersen RC, Sperling RA, van der Flier WM, Villemagne VL, Visser PJ, Vos SJ. Suspected non-Alzheimer disease pathophysiology--concept and controversy. Nat Rev Neurol. 2016 Feb; 12(2):117-24. PMID: 26782335; PMCID: PMC4784257.
      30. Jung NY, Han CE, Kim HJ, Yoo SW, Kim HJ, Kim EJ, Na DL, Lockhart SN, Jagust W, Seong JK, Seo SW. Tract-Specific Correlates of Neuropsychological Deficits in Patients with Subcortical Vascular Cognitive Impairment. J Alzheimers Dis. 2016; 50(4):1125-35. PMID: 26836179.
        View in: PubMed
      31. Smith CT, Wallace DL, Dang LC, Aarts E, Jagust W, D'Esposito M, Boettiger CA. Modulation of impulsivity and reward sensitivity in intertemporal choice by striatal and midbrain dopamine synthesis in healthy adults. J Neurophysiol. 2016 Mar; 115(3):1146-56. PMID: 26683066; PMCID: PMC4808128 [Available on 03/01/17].
      32. Jagust W. Is amyloid-ß harmful to the brain? Insights from human imaging studies. Brain. 2016 Jan; 139(Pt 1):23-30. PMID: 26614753.
        View in: PubMed
      33. Tosun D, Schuff N, Jagust W, Weiner MW. Discriminative Power of Arterial Spin Labeling Magnetic Resonance Imaging and 18F-Fluorodeoxyglucose Positron Emission Tomography Changes for Amyloid-ß-Positive Subjects in the Alzheimer's Disease Continuum. Neurodegener Dis. 2016; 16(1-2):87-94. PMID: 26560336.
        View in: PubMed
      34. Lazaris A, Hwang KS, Goukasian N, Ramirez LM, Eastman J, Blanken AE, Teng E, Gylys K, Cole G, Saykin AJ, Shaw LM, Trojanowski JQ, Jagust W, Weiner MW, Apostolova LG. Alzheimer risk genes modulate the relationship between plasma apoE and cortical PiB binding. Neurol Genet. 2015 Oct; 1(3):e22. PMID: 27066559; PMCID: PMC4809461.
      35. Schreiber S, Landau SM, Fero A, Schreiber F, Jagust W. Comparison of Visual and Quantitative Florbetapir F 18 Positron Emission Tomography Analysis in Predicting Mild Cognitive Impairment Outcomes. JAMA Neurol. 2015 Oct; 72(10):1183-90. PMID: 26280102.
        View in: PubMed
      36. Altmann A, Ng B, Landau SM, Jagust W, Greicius MD. Regional brain hypometabolism is unrelated to regional amyloid plaque burden. Brain. 2015 Dec; 138(Pt 12):3734-46. PMID: 26419799; PMCID: PMC4806718 [Available on 12/01/16].
      37. Ossenkoppele R, Cohn-Sheehy BI, La Joie R, Vogel JW, Möller C, Lehmann M, van Berckel BN, Seeley WW, Pijnenburg YA, Gorno-Tempini ML, Kramer JH, Barkhof F, Rosen HJ, van der Flier WM, Jagust W, Miller BL, Scheltens P, Rabinovici GD. Atrophy patterns in early clinical stages across distinct phenotypes of Alzheimer's disease. Hum Brain Mapp. 2015 Nov; 36(11):4421-37. PMID: 26260856; PMCID: PMC4692964.
      38. Ramanan VK, Risacher SL, Nho K, Kim S, Shen L, McDonald BC, Yoder KK, Hutchins GD, West JD, Tallman EF, Gao S, Foroud TM, Farlow MR, De Jager PL, Bennett DA, Aisen PS, Petersen RC, Jack CR, Toga AW, Green RC, Jagust W, Weiner MW, Saykin AJ. GWAS of longitudinal amyloid accumulation on 18F-florbetapir PET in Alzheimer's disease implicates microglial activation gene IL1RAP. Brain. 2015 Oct; 138(Pt 10):3076-88. PMID: 26268530; PMCID: PMC4671479 [Available on 10/01/16].
      39. Lehmann M, Madison C, Ghosh PM, Miller ZA, Greicius MD, Kramer JH, Coppola G, Miller BL, Jagust W, Gorno-Tempini ML, Seeley WW, Rabinovici GD. Loss of functional connectivity is greater outside the default mode network in nonfamilial early-onset Alzheimer's disease variants. Neurobiol Aging. 2015 Oct; 36(10):2678-86. PMID: 26242705; PMCID: PMC4698410.
      40. Ossenkoppele R, Pijnenburg YA, Perry DC, Cohn-Sheehy BI, Scheltens NM, Vogel JW, Kramer JH, van der Vlies AE, La Joie R, Rosen HJ, van der Flier WM, Grinberg LT, Rozemuller AJ, Huang EJ, van Berckel BN, Miller BL, Barkhof F, Jagust W, Scheltens P, Seeley WW, Rabinovici GD. The behavioural/dysexecutive variant of Alzheimer's disease: clinical, neuroimaging and pathological features. Brain. 2015 Sep; 138(Pt 9):2732-49. PMID: 26141491; PMCID: PMC4623840.
      41. Jagust W, Landau SM, Koeppe RA, Reiman EM, Chen K, Mathis CA, Price JC, Foster NL, Wang AY. The Alzheimer's Disease Neuroimaging Initiative 2 PET Core: 2015. Alzheimers Dement. 2015 Jul; 11(7):757-71. PMID: 26194311; PMCID: PMC4510459.
      42. Naasan G, Rabinovici GD, Ghosh P, Elofson JD, Miller BL, Coppola G, Karydas A, Fong J, Perry D, Lee SE, Yokoyama JS, Seeley WW, Kramer JH, Weiner MW, Schuff N, Jagust W, Grinberg LT, Pribadi M, Yang Z, Sears R, Klein E, Wojta K, Rosen HJ. Amyloid in dementia associated with familial FTLD: not an innocent bystander. Neurocase. 2016; 22(1):76-83. PMID: 26040468; PMCID: PMC4662906 [Available on 02/01/17].
      43. Mander BA, Marks SM, Vogel JW, Rao V, Lu B, Saletin JM, Ancoli-Israel S, Jagust W, Walker MP. ß-amyloid disrupts human NREM slow waves and related hippocampus-dependent memory consolidation. Nat Neurosci. 2015 Jul; 18(7):1051-7. PMID: 26030850; PMCID: PMC4482795.
      44. Weiner MW, Veitch DP, Aisen PS, Beckett LA, Cairns NJ, Cedarbaum J, Green RC, Harvey D, Jack CR, Jagust W, Luthman J, Morris JC, Petersen RC, Saykin AJ, Shaw L, Shen L, Schwarz A, Toga AW, Trojanowski JQ. 2014 Update of the Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception. Alzheimers Dement. 2015 Jun; 11(6):e1-120. PMID: 26073027.
        View in: PubMed
      45. Ossenkoppele R, Jansen WJ, Rabinovici GD, Knol DL, van der Flier WM, van Berckel BN, Scheltens P, Visser PJ. Prevalence of amyloid PET positivity in dementia syndromes: a meta-analysis. JAMA. 2015 May 19; 313(19):1939-49. PMID: 25988463; PMCID: PMC4517678.
      46. Jansen WJ, Ossenkoppele R, Knol DL, Tijms BM, Scheltens P, Verhey FR, Visser PJ. Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis. JAMA. 2015 May 19; 313(19):1924-38. PMID: 25988462; PMCID: PMC4486209.
      47. Wallace DL, Aarts E, d'Oleire Uquillas F, Dang LC, Greer SM, Jagust W, D'Esposito M. Genotype status of the dopamine-related catechol-O-methyltransferase (COMT) gene corresponds with desirability of "unhealthy" foods. Appetite. 2015 Sep; 92:74-80. PMID: 25963102; PMCID: PMC4629853.
      48. Risacher SL, Kim S, Nho K, Foroud T, Shen L, Petersen RC, Jack CR, Beckett LA, Aisen PS, Koeppe RA, Jagust W, Shaw LM, Trojanowski JQ, Weiner MW, Saykin AJ. APOE effect on Alzheimer's disease biomarkers in older adults with significant memory concern. Alzheimers Dement. 2015 Dec; 11(12):1417-1429. PMID: 25960448; PMCID: PMC4637003 [Available on 12/01/16].
      49. Villeneuve S, Rabinovici GD, Cohn-Sheehy BI, Madison C, Ayakta N, Ghosh PM, La Joie R, Arthur-Bentil SK, Vogel JW, Marks SM, Lehmann M, Rosen HJ, Reed B, Olichney J, Boxer AL, Miller BL, Borys E, Jin LW, Huang EJ, Grinberg LT, DeCarli C, Seeley WW, Jagust W. Existing Pittsburgh Compound-B positron emission tomography thresholds are too high: statistical and pathological evaluation. Brain. 2015 Jul; 138(Pt 7):2020-33. PMID: 25953778; PMCID: PMC4806716.
      50. Mattsson N, Insel PS, Donohue M, Jagust W, Sperling R, Aisen P, Weiner MW. Predicting Reduction of Cerebrospinal Fluid ß-Amyloid 42 in Cognitively Healthy Controls. JAMA Neurol. 2015 May; 72(5):554-60. PMID: 25775167.
        View in: PubMed
      51. Toledo JB, Bjerke M, Da X, Landau SM, Foster NL, Jagust W, Jack C, Weiner M, Davatzikos C, Shaw LM, Trojanowski JQ. Nonlinear Association Between Cerebrospinal Fluid and Florbetapir F-18 ß-Amyloid Measures Across the Spectrum of Alzheimer Disease. JAMA Neurol. 2015 May; 72(5):571-81. PMID: 25822737.
        View in: PubMed
      52. Boutchko R, Mitra D, Baker SL, Jagust W, Gullberg GT. Clustering-initiated factor analysis application for tissue classification in dynamic brain positron emission tomography. J Cereb Blood Flow Metab. 2015 Jul; 35(7):1104-11. PMID: 25899294; PMCID: PMC4640278.
      53. Caroli A, Prestia A, Wade S, Chen K, Ayutyanont N, Landau SM, Madison CM, Haense C, Herholz K, Reiman EM, Jagust W, Frisoni GB. Alzheimer Disease Biomarkers as Outcome Measures for Clinical Trials in MCI. Alzheimer Dis Assoc Disord. 2015 Apr-Jun; 29(2):101-9. PMID: 25437302; PMCID: PMC4437812.
      54. Landau SM, Fero A, Baker SL, Koeppe R, Mintun M, Chen K, Reiman EM, Jagust W. Measurement of longitudinal ß-amyloid change with 18F-florbetapir PET and standardized uptake value ratios. J Nucl Med. 2015 Apr; 56(4):567-74. PMID: 25745095.
        View in: PubMed
      55. Chen K, Roontiva A, Thiyyagura P, Lee W, Liu X, Ayutyanont N, Protas H, Luo JL, Bauer R, Reschke C, Bandy D, Koeppe RA, Fleisher AS, Caselli RJ, Landau S, Jagust W, Weiner MW, Reiman EM. Improved power for characterizing longitudinal amyloid-ß PET changes and evaluating amyloid-modifying treatments with a cerebral white matter reference region. J Nucl Med. 2015 Apr; 56(4):560-6. PMID: 25745091.
        View in: PubMed
      56. Villeneuve S, Jagust W. Imaging Vascular Disease and Amyloid in the Aging Brain: Implications for Treatment. J Prev Alzheimers Dis. 2015 Mar; 2(1):64-70. PMID: 25844350.
        View in: PubMed
      57. Mattsson N, Insel PS, Aisen PS, Jagust W, Mackin S, Weiner M. Brain structure and function as mediators of the effects of amyloid on memory. Neurology. 2015 Mar 17; 84(11):1136-44. PMID: 25681451; PMCID: PMC4371407.
      58. Apostolova LG, Hwang KS, Avila D, Elashoff D, Kohannim O, Teng E, Sokolow S, Jack CR, Jagust W, Shaw L, Trojanowski JQ, Weiner MW, Thompson PM. Brain amyloidosis ascertainment from cognitive, imaging, and peripheral blood protein measures. Neurology. 2015 Feb 17; 84(7):729-37. PMID: 25609767; PMCID: PMC4336101.
      59. Mattsson N, Insel PS, Donohue M, Landau S, Jagust W, Shaw LM, Trojanowski JQ, Zetterberg H, Blennow K, Weiner MW. Independent information from cerebrospinal fluid amyloid-ß and florbetapir imaging in Alzheimer's disease. Brain. 2015 Mar; 138(Pt 3):772-83. PMID: 25541191; PMCID: PMC4339769.
      60. Ossenkoppele R, Schonhaut DR, Baker SL, O'Neil JP, Janabi M, Ghosh PM, Santos M, Miller ZA, Bettcher BM, Gorno-Tempini ML, Miller BL, Jagust W, Rabinovici GD. Tau, amyloid, and hypometabolism in a patient with posterior cortical atrophy. Ann Neurol. 2015 Feb; 77(2):338-42. PMID: 25448043; PMCID: PMC4382124.
      61. Schmidt ME, Chiao P, Klein G, Matthews D, Thurfjell L, Cole PE, Margolin R, Landau S, Foster NL, Mason NS, De Santi S, Suhy J, Koeppe RA, Jagust W. The influence of biological and technical factors on quantitative analysis of amyloid PET: Points to consider and recommendations for controlling variability in longitudinal data. Alzheimers Dement. 2015 Sep; 11(9):1050-68. PMID: 25457431.
        View in: PubMed
      62. Schicktanz S, Schweda M, Ballenger JF, Fox PJ, Halpern J, Kramer JH, Micco G, Post SG, Thompson C, Knight RT, Jagust W. Before it is too late: professional responsibilities in late-onset Alzheimer's research and pre-symptomatic prediction. Front Hum Neurosci. 2014; 8:921. PMID: 25477802; PMCID: PMC4238325.
      63. Elman JA, Madison CM, Baker SL, Vogel JW, Marks SM, Crowley S, O'Neil JP, Jagust W. Effects of Beta-Amyloid on Resting State Functional Connectivity Within and Between Networks Reflect Known Patterns of Regional Vulnerability. Cereb Cortex. 2016 Feb; 26(2):695-707. PMID: 25405944; PMCID: PMC4712800 [Available on 02/01/17].
      64. Dowling NM, Johnson SC, Gleason CE, Jagust W. The mediational effects of FDG hypometabolism on the association between cerebrospinal fluid biomarkers and neurocognitive function. Neuroimage. 2015 Jan 15; 105:357-68. PMID: 25450107; PMCID: PMC4262609.
      65. Klunk WE, Koeppe RA, Price JC, Benzinger TL, Devous MD, Jagust W, Johnson KA, Mathis CA, Minhas D, Pontecorvo MJ, Rowe CC, Skovronsky DM, Mintun MA. The Centiloid Project: standardizing quantitative amyloid plaque estimation by PET. Alzheimers Dement. 2015 Jan; 11(1):1-15.e1-4. PMID: 25443857; PMCID: PMC4300247.
      66. Elman JA, Oh H, Madison CM, Baker SL, Vogel JW, Marks SM, Crowley S, O'Neil JP, Jagust W. Neural compensation in older people with brain amyloid-ß deposition. Nat Neurosci. 2014 Oct; 17(10):1316-8. PMID: 25217827; PMCID: PMC4177011.
      67. Mattsson N, Insel PS, Landau S, Jagust W, Donohue M, Shaw LM, Trojanowski JQ, Zetterberg H, Blennow K, Weiner M. Diagnostic accuracy of CSF Ab42 and florbetapir PET for Alzheimer's disease. Ann Clin Transl Neurol. 2014 Aug; 1(8):534-43. PMID: 25356425; PMCID: PMC4184556.
      68. Wirth M, Villeneuve S, La Joie R, Marks SM, Jagust W. Gene-environment interactions: lifetime cognitive activity, APOE genotype, and ß-amyloid burden. J Neurosci. 2014 Jun 18; 34(25):8612-7. PMID: 24948815; PMCID: PMC4061397.
      69. Villeneuve S, Reed BR, Madison CM, Wirth M, Marchant NL, Kriger S, Mack WJ, Sanossian N, DeCarli C, Chui HC, Weiner MW, Jagust W. Vascular risk and Aß interact to reduce cortical thickness in AD vulnerable brain regions. Neurology. 2014 Jul 01; 83(1):40-7. PMID: 24907234; PMCID: PMC4114172.
      70. Weiner MW, Veitch DP, Hayes J, Neylan T, Grafman J, Aisen PS, Petersen RC, Jack C, Jagust W, Trojanowski JQ, Shaw LM, Saykin AJ, Green RC, Harvey D, Toga AW, Friedl KE, Pacifico A, Sheline Y, Yaffe K, Mohlenoff B. Effects of traumatic brain injury and posttraumatic stress disorder on Alzheimer's disease in veterans, using the Alzheimer's Disease Neuroimaging Initiative. Alzheimers Dement. 2014 Jun; 10(3 Suppl):S226-35. PMID: 24924673; PMCID: PMC4392759.
      71. Wallace DL, Aarts E, Dang LC, Greer SM, Jagust W, D'Esposito M. Dorsal striatal dopamine, food preference and health perception in humans. PLoS One. 2014; 9(5):e96319. PMID: 24806534; PMCID: PMC4012945.
      72. Jagust W. Time for tau. Brain. 2014 Jun; 137(Pt 6):1570-1. PMID: 24736306.
        View in: PubMed
      73. Landau SM, Thomas BA, Thurfjell L, Schmidt M, Margolin R, Mintun M, Pontecorvo M, Baker SL, Jagust W. Amyloid PET imaging in Alzheimer's disease: a comparison of three radiotracers. Eur J Nucl Med Mol Imaging. 2014 Jul; 41(7):1398-407. PMID: 24647577; PMCID: PMC4055504.
      74. Laforce R, Tosun D, Ghosh P, Lehmann M, Madison CM, Weiner MW, Miller BL, Jagust W, Rabinovici GD. Parallel ICA of FDG-PET and PiB-PET in three conditions with underlying Alzheimer's pathology. Neuroimage Clin. 2014; 4:508-16. PMID: 24818077; PMCID: PMC3984448.
      75. Mattsson N, Tosun D, Insel PS, Simonson A, Jack CR, Beckett LA, Donohue M, Jagust W, Schuff N, Weiner MW. Association of brain amyloid-ß with cerebral perfusion and structure in Alzheimer's disease and mild cognitive impairment. Brain. 2014 May; 137(Pt 5):1550-61. PMID: 24625697; PMCID: PMC3999717.
      76. Toledo JB, Weiner MW, Wolk DA, Da X, Chen K, Arnold SE, Jagust W, Jack C, Reiman EM, Davatzikos C, Shaw LM, Trojanowski JQ. Neuronal injury biomarkers and prognosis in ADNI subjects with normal cognition. Acta Neuropathol Commun. 2014; 2(1):26. PMID: 24602322.
        View in: PubMed
      77. Wirth M, Haase CM, Villeneuve S, Vogel J, Jagust W. Neuroprotective pathways: lifestyle activity, brain pathology, and cognition in cognitively normal older adults. Neurobiol Aging. 2014 Aug; 35(8):1873-82. PMID: 24656834; PMCID: PMC4019766.
      78. Aarts E, Wallace DL, Dang LC, Jagust W, Cools R, D'Esposito M. Dopamine and the cognitive downside of a promised bonus. Psychol Sci. 2014 Apr; 25(4):1003-9. PMID: 24525265; PMCID: PMC4163051.
      79. Reed B, Villeneuve S, Mack W, DeCarli C, Chui HC, Jagust W. Associations between serum cholesterol levels and cerebral amyloidosis. JAMA Neurol. 2014 Feb; 71(2):195-200. PMID: 24378418; PMCID: PMC4083819.
      80. Lee JY, Park S, Mackin S, Ewers M, Chui H, Jagust W, Insel PS, Weiner MW. Differences in prefrontal, limbic, and white matter lesion volumes according to cognitive status in elderly patients with first-onset subsyndromal depression. PLoS One. 2014; 9(1):e87747. PMID: 24498184; PMCID: PMC3909227.
      81. Villeneuve S, Reed BR, Wirth M, Haase CM, Madison CM, Ayakta N, Mack W, Mungas D, Chui HC, DeCarli C, Weiner MW, Jagust W. Cortical thickness mediates the effect of ß-amyloid on episodic memory. Neurology. 2014 Mar 04; 82(9):761-7. PMID: 24489134; PMCID: PMC3945649.
      82. He BJ, Nolte G, Nagata K, Takano D, Yamazaki T, Fujimaki Y, Maeda T, Satoh Y, Heckers S, George MS, Lopes da Silva F, de Munck JC, Van Houdt PJ, Verdaasdonk RM, Ossenblok P, Mullinger K, Bowtell R, Bagshaw AP, Keeser D, Karch S, Segmiller F, Hantschk I, Berman A, Padberg F, Pogarell O, Scharnowski F, Karch S, Hümmer S, Keeser D, Paolini M, Kirsch V, Koller G, Rauchmann B, Kupka M, Blautzik J, Pogarell O, Razavi N, Jann K, Koenig T, Kottlow M, Hauf M, Strik W, Dierks T, Gotman J, Vulliemoz S, Lu Y, Zhang H, Yang L, Worrell G, He B, Gruber O, Piguet C, Hubl D, Homan P, Kindler J, Dierks T, Kim K, Steinhoff U, Wakai R, Koenig T, Kottlow M, Melie-García L, Mucci A, Volpe U, Prinster A, Salvatore M, Galderisi S, Linden DE, Brandeis D, Schroeder CE, Kayser C, Panzeri S, Kleinschmidt A, Ritter P, Walther S, Haueisen J, Lau S, Flemming L, Sonntag H, Maess B, Knösche TR, Lanfer B, Dannhauer M, Wolters CH, Stenroos M, Haueisen J, Wolters C, Aydin U, Lanfer B, Lew S, Lucka F, Ruthotto L, Vorwerk J, Wagner S, Ramon C, Guan C, Ang KK, Chua SG, Kuah WK, Phua KS, Chew E, Zhou H, Chuang KH, Ang BT, Wang C, Zhang H, Yang H, Chin ZY, Yu H, Pan Y, Collins L, Mainsah B, Colwell K, Morton K, Ryan D, Sellers E, Caves K, Throckmorton S, Kübler A, Holz EM, Zickler C, Sellers E, Ryan D, Brown K, Colwell K, Mainsah B, Caves K, Throckmorton S, Collins L, Wennberg R, Ahlfors SP, Grova C, Chowdhury R, Hedrich T, Heers M, Zelmann R, Hall JA, Lina JM, Kobayashi E, Oostendorp T, van Dam P, Oosterhof P, Linnenbank A, Coronel R, van Dessel P, de Bakker J, Rossion B, Jacques C, Witthoft N, Weiner KS, Foster BL, Miller KJ, Hermes D, Parvizi J, Grill-Spector K, Recanzone GH, Murray MM, Haynes JD, Richiardi J, Greicius M, De Lucia M, Müller KR, Formisano E, Smieskova R, Schmidt A, Bendfeldt K, Walter A, Riecher-Rössler A, Borgwardt S, Fusar-Poli P, Eliez S, Schmidt A, Sekihara K, Nagarajan SS, Schoffelen JM, Guggisberg AG, Nolte G, Balazs S, Kermanshahi K, Kiesenhofer W, Binder H, Rattay F, Antal A, Chaieb L, Paulus W, Bodis-Wollner I, Maurer K, Fein G, Camchong J, Johnstone J, Cardenas-Nicolson V, Fiederer LD, Lucka F, Yang S, Vorwerk J, Dümpelmann M, Cosandier-Rimélé D, Schulze-Bonhage A, Aertsen A, Speck O, Wolters CH, Ball T, Fuchs M, Wagner M, Kastner J, Tech R, Dinh C, Haueisen J, Baumgarten D, Hämäläinen MS, Lau S, Vogrin SJ, D'Souza W, Haueisen J, Cook MJ, Custo A, Van De Ville D, Vulliemoz S, Grouiller F, Michel CM, Malmivuo J, Aydin U, Vorwerk J, Küpper P, Heers M, Kugel H, Wellmer J, Kellinghaus C, Scherg M, Rampp S, Wolters C, Storti SF, Boscolo Galazzo I, Del Felice A, Pizzini FB, Arcaro C, Formaggio E, Mai R, Manganotti P, Koessler L, Vignal J, Cecchin T, Colnat-Coulbois S, Vespignani H, Ramantani G, Maillard L, Rektor I, Kuba R, Brázdil M, Chrastina J, Rektorova I, van Mierlo P, Carrette E, Strobbe G, Montes-Restrepo V, Vonck K, Vandenberghe S, Ahmed B, Brodely C, Carlson C, Kuzniecky R, Devinsky O, French J, Thesen T, Bénis D, David O, Lachaux JP, Seigneuret E, Krack P, Fraix V, Chabardès S, Bastin J, Jann K, Gee D, Kilroy E, Cannon T, Wang DJ, Hale JR, Mayhew SD, Przezdzik I, Arvanitis TN, Bagshaw AP, Plomp G, Quairiaux C, Astolfi L, Michel CM, Mayhew SD, Mullinger KJ, Bagshaw AP, Bowtell R, Francis ST, Schouten AC, Campfens SF, van der Kooij H, Koles Z, Lind J, Flor-Henry P, Wirth M, Haase CM, Villeneuve S, Vogel J, Jagust W, Kambeitz-Ilankovic L, Simon-Vermot L, Gesierich B, Duering M, Ewers M. Abstracts of Presentations at the International Conference on Basic and Clinical Multimodal Imaging (BaCI), a Joint Conference of the International Society for Neuroimaging in Psychiatry (ISNIP), the International Society for Functional Source Imaging (ISFSI), the International Society for Bioelectromagnetism (ISBEM), the International Society for Brain Electromagnetic Topography (ISBET), and the EEG and Clinical Neuroscience Society (ECNS), in Geneva, Switzerland, September 5-8, 2013. Clin EEG Neurosci. 2013 Dec 24. PMID: 24368763.
        View in: PubMed
      83. Sánchez-Juan P, Ghosh PM, Hagen J, Gesierich B, Henry M, Grinberg LT, O'Neil JP, Janabi M, Huang EJ, Trojanowski JQ, Vinters HV, Gorno-Tempini M, Seeley WW, Boxer AL, Rosen HJ, Kramer JH, Miller BL, Jagust W, Rabinovici GD. Practical utility of amyloid and FDG-PET in an academic dementia center. Neurology. 2014 Jan 21; 82(3):230-8. PMID: 24353340; PMCID: PMC3902757.
      84. Wirth M, Villeneuve S, Haase CM, Madison CM, Oh H, Landau SM, Rabinovici GD, Jagust W. Associations between Alzheimer disease biomarkers, neurodegeneration, and cognition in cognitively normal older people. JAMA Neurol. 2013 Dec; 70(12):1512-9. PMID: 24166579; PMCID: PMC4962545.
      85. Landau SM, Lu M, Joshi AD, Pontecorvo M, Mintun MA, Trojanowski JQ, Shaw LM, Jagust W. Comparing positron emission tomography imaging and cerebrospinal fluid measurements of ß-amyloid. Ann Neurol. 2013 Dec; 74(6):826-36. PMID: 23536396; PMCID: PMC3748164.
      86. Oh H, Jagust W. Frontotemporal network connectivity during memory encoding is increased with aging and disrupted by beta-amyloid. J Neurosci. 2013 Nov 20; 33(47):18425-37. PMID: 24259567; PMCID: PMC3834050.
      87. Jagust W. Biomarkers and brain connectivity. JAMA Neurol. 2013 Oct; 70(10):1233-4. PMID: 23959142.
        View in: PubMed
      88. Lo RY, Jagust W. Effect of cognitive reserve markers on Alzheimer pathologic progression. Alzheimer Dis Assoc Disord. 2013 Oct-Dec; 27(4):343-50. PMID: 23552443; PMCID: PMC3745532.
      89. Lehmann M, Ghosh PM, Madison C, Karydas A, Coppola G, O'Neil JP, Huang Y, Miller BL, Jagust W, Rabinovici GD. Greater medial temporal hypometabolism and lower cortical amyloid burden in ApoE4-positive AD patients. J Neurol Neurosurg Psychiatry. 2014 Mar; 85(3):266-73. PMID: 23965289; PMCID: PMC3946299.
      90. Weiner MW, Veitch DP, Aisen PS, Beckett LA, Cairns NJ, Green RC, Harvey D, Jack CR, Jagust W, Liu E, Morris JC, Petersen RC, Saykin AJ, Schmidt ME, Shaw L, Shen L, Siuciak JA, Soares H, Toga AW, Trojanowski JQ. The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception. Alzheimers Dement. 2013 Sep; 9(5):e111-94. PMID: 23932184; PMCID: PMC4108198.
      91. Haight TJ, Landau SM, Carmichael O, Schwarz C, DeCarli C, Jagust W. Dissociable effects of Alzheimer disease and white matter hyperintensities on brain metabolism. JAMA Neurol. 2013 Aug; 70(8):1039-45. PMID: 23779022; PMCID: PMC3779687.
      92. Frisoni GB, Bocchetta M, Chételat G, Rabinovici GD, de Leon MJ, Kaye J, Reiman EM, Scheltens P, Barkhof F, Black SE, Brooks DJ, Carrillo MC, Fox NC, Herholz K, Nordberg A, Jack CR, Jagust W, Johnson KA, Rowe CC, Sperling RA, Thies W, Wahlund LO, Weiner MW, Pasqualetti P, Decarli C. Imaging markers for Alzheimer disease: which vs how. Neurology. 2013 Jul 30; 81(5):487-500. PMID: 23897875; PMCID: PMC3776529.
      93. Mander BA, Rao V, Lu B, Saletin JM, Ancoli-Israel S, Jagust W, Walker MP. Impaired prefrontal sleep spindle regulation of hippocampal-dependent learning in older adults. Cereb Cortex. 2014 Dec; 24(12):3301-9. PMID: 23901074; PMCID: PMC4224242.
      94. Lehmann M, Madison CM, Ghosh PM, Seeley WW, Mormino E, Greicius MD, Gorno-Tempini ML, Kramer JH, Miller BL, Jagust W, Rabinovici GD. Intrinsic connectivity networks in healthy subjects explain clinical variability in Alzheimer's disease. Proc Natl Acad Sci U S A. 2013 Jul 09; 110(28):11606-11. PMID: 23798398; PMCID: PMC3710820.
      95. Chao LL, Decarli C, Kriger S, Truran D, Zhang Y, Laxamana J, Villeneuve S, Jagust W, Sanossian N, Mack WJ, Chui HC, Weiner MW. Associations between white matter hyperintensities and ß amyloid on integrity of projection, association, and limbic fiber tracts measured with diffusion tensor MRI. PLoS One. 2013; 8(6):e65175. PMID: 23762308; PMCID: PMC3675157.
      96. Risacher SL, Kim S, Shen L, Nho K, Foroud T, Green RC, Petersen RC, Jack CR, Aisen PS, Koeppe RA, Jagust W, Shaw LM, Trojanowski JQ, Weiner MW, Saykin AJ. The role of apolipoprotein E (APOE) genotype in early mild cognitive impairment (E-MCI). Front Aging Neurosci. 2013; 5:11. PMID: 23554593; PMCID: PMC3612590.
      97. Marchant NL, Reed BR, Sanossian N, Madison CM, Kriger S, Dhada R, Mack WJ, DeCarli C, Weiner MW, Mungas DM, Chui HC, Jagust W. The aging brain and cognition: contribution of vascular injury and aß to mild cognitive dysfunction. JAMA Neurol. 2013 Apr; 70(4):488-95. PMID: 23400560; PMCID: PMC3771392.
      98. Ossenkoppele R, Madison C, Oh H, Wirth M, van Berckel BN, Jagust W. Is verbal episodic memory in elderly with amyloid deposits preserved through altered neuronal function? Cereb Cortex. 2014 Aug; 24(8):2210-8. PMID: 23537530; PMCID: PMC4089385.
      99. Wirth M, Madison CM, Rabinovici GD, Oh H, Landau SM, Jagust W. Alzheimer's disease neurodegenerative biomarkers are associated with decreased cognitive function but not ß-amyloid in cognitively normal older individuals. J Neurosci. 2013 Mar 27; 33(13):5553-63. PMID: 23536070.
        View in: PubMed
      100. Swaminathan S, Risacher SL, Yoder KK, West JD, Shen L, Kim S, Inlow M, Foroud T, Jagust W, Koeppe RA, Mathis CA, Shaw LM, Trojanowski JQ, Soares H, Aisen PS, Petersen RC, Weiner MW, Saykin AJ. Association of plasma and cortical amyloid beta is modulated by APOE e4 status. Alzheimers Dement. 2014 Jan; 10(1):e9-e18. PMID: 23541187; PMCID: PMC3750076.
      101. Wirth M, Oh H, Mormino EC, Markley C, Landau SM, Jagust W. The effect of amyloid ß on cognitive decline is modulated by neural integrity in cognitively normal elderly. Alzheimers Dement. 2013 Nov; 9(6):687-698.e1. PMID: 23474040; PMCID: PMC3823816.
      102. Jagust W. Apolipoprotein E, neurodegeneration, and Alzheimer disease. JAMA Neurol. 2013 Mar 01; 70(3):299-300. PMID: 23599927.
        View in: PubMed
      103. Ramanan VK, Risacher SL, Nho K, Kim S, Swaminathan S, Shen L, Foroud TM, Hakonarson H, Huentelman MJ, Aisen PS, Petersen RC, Green RC, Jack CR, Koeppe RA, Jagust W, Weiner MW, Saykin AJ. APOE and BCHE as modulators of cerebral amyloid deposition: a florbetapir PET genome-wide association study. Mol Psychiatry. 2014 Mar; 19(3):351-7. PMID: 23419831; PMCID: PMC3661739.
      104. Oh H, Madison C, Villeneuve S, Markley C, Jagust W. Association of gray matter atrophy with age, ß-amyloid, and cognition in aging. Cereb Cortex. 2014 Jun; 24(6):1609-18. PMID: 23389995; PMCID: PMC4014182.
      105. Jack CR, Knopman DS, Jagust W, Petersen RC, Weiner MW, Aisen PS, Shaw LM, Vemuri P, Wiste HJ, Weigand SD, Lesnick TG, Pankratz VS, Donohue MC, Trojanowski JQ. Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers. Lancet Neurol. 2013 Feb; 12(2):207-16. PMID: 23332364; PMCID: PMC3622225.
      106. Prestia A, Caroli A, Herholz K, Reiman E, Chen K, Jagust W, Frisoni GB. Diagnostic accuracy of markers for prodromal Alzheimer's disease in independent clinical series. Alzheimers Dement. 2013 Nov; 9(6):677-86. PMID: 23375562; PMCID: PMC4058442.
      107. Kantarci K, Gunter JL, Tosakulwong N, Weigand SD, Senjem MS, Petersen RC, Aisen PS, Jagust W, Weiner MW, Jack CR. Focal hemosiderin deposits and ß-amyloid load in the ADNI cohort. Alzheimers Dement. 2013 Oct; 9(5 Suppl):S116-23. PMID: 23375568; PMCID: PMC3770782.
      108. Lehmann M, Ghosh PM, Madison C, Laforce R, Corbetta-Rastelli C, Weiner MW, Greicius MD, Seeley WW, Gorno-Tempini ML, Rosen HJ, Miller BL, Jagust W, Rabinovici GD. Diverging patterns of amyloid deposition and hypometabolism in clinical variants of probable Alzheimer's disease. Brain. 2013 Mar; 136(Pt 3):844-58. PMID: 23358601; PMCID: PMC3580269.
      109. Mander BA, Rao V, Lu B, Saletin JM, Lindquist JR, Ancoli-Israel S, Jagust W, Walker MP. Prefrontal atrophy, disrupted NREM slow waves and impaired hippocampal-dependent memory in aging. Nat Neurosci. 2013 Mar; 16(3):357-64. PMID: 23354332; PMCID: PMC4286370.
      110. Jagust W. Vulnerable neural systems and the borderland of brain aging and neurodegeneration. Neuron. 2013 Jan 23; 77(2):219-34. PMID: 23352159; PMCID: PMC3558930.
      111. Wu X, Li J, Ayutyanont N, Protas H, Jagust W, Fleisher A, Reiman E, Yao L, Chen K. The receiver operational characteristic for binary classification with multiple indices and its application to the neuroimaging study of Alzheimer's disease. IEEE/ACM Trans Comput Biol Bioinform. 2013 Jan-Feb; 10(1):173-80. PMID: 23702553.
        View in: PubMed
      112. Foster NL, Jagust W, Fox NC. A peek behind the curtain: amyloid imaging, referrals, and specialist memory evaluations. Alzheimer Dis Assoc Disord. 2013 Jan-Mar; 27(1):1-3. PMID: 23411640.
        View in: PubMed
      113. Alkalay A, Rabinovici GD, Zimmerman G, Agarwal N, Kaufer D, Miller BL, Jagust W, Soreq H. Plasma acetylcholinesterase activity correlates with intracerebral ß-amyloid load. Curr Alzheimer Res. 2013 Jan; 10(1):48-56. PMID: 23157337; PMCID: PMC3768143.
      114. Jagust W, Landau SM. Apolipoprotein E, not fibrillar ß-amyloid, reduces cerebral glucose metabolism in normal aging. J Neurosci. 2012 Dec 12; 32(50):18227-33. PMID: 23238736; PMCID: PMC3537830.
      115. Stricker NH, Dodge HH, Dowling NM, Han SD, Erosheva EA, Jagust W. CSF biomarker associations with change in hippocampal volume and precuneus thickness: implications for the Alzheimer's pathological cascade. Brain Imaging Behav. 2012 Dec; 6(4):599-609. PMID: 22614327; PMCID: PMC3656503.
      116. Landau SM, Breault C, Joshi AD, Pontecorvo M, Mathis CA, Jagust W, Mintun MA. Amyloid-ß imaging with Pittsburgh compound B and florbetapir: comparing radiotracers and quantification methods. J Nucl Med. 2013 Jan; 54(1):70-7. PMID: 23166389; PMCID: PMC3747730.
      117. Dang LC, O'Neil JP, Jagust W. Genetic effects on behavior are mediated by neurotransmitters and large-scale neural networks. Neuroimage. 2013 Feb 01; 66:203-14. PMID: 23142068; PMCID: PMC3587048.
      118. Jagust W. Tracking brain amyloid-ß in presymptomatic Alzheimer's disease. Lancet Neurol. 2012 Dec; 11(12):1018-20. PMID: 23137951.
        View in: PubMed
      119. Toledo JB, Toledo E, Weiner MW, Jack CR, Jagust W, Lee VM, Shaw LM, Trojanowski JQ. Cardiovascular risk factors, cortisol, and amyloid-ß deposition in Alzheimer's Disease Neuroimaging Initiative. Alzheimers Dement. 2012 Nov; 8(6):483-9. PMID: 23102118; PMCID: PMC3668456.
      120. Haight TJ, Jagust W. Relative contributions of biomarkers in Alzheimer's disease. Ann Epidemiol. 2012 Dec; 22(12):868-75. PMID: 23102709; PMCID: PMC3510749.
      121. Landau SM, Mintun MA, Joshi AD, Koeppe RA, Petersen RC, Aisen PS, Weiner MW, Jagust W. Amyloid deposition, hypometabolism, and longitudinal cognitive decline. Ann Neurol. 2012 Oct; 72(4):578-86. PMID: 23109153; PMCID: PMC3786871.
      122. Cardenas VA, Reed B, Chao LL, Chui H, Sanossian N, DeCarli CC, Mack W, Kramer J, Hodis HN, Yan M, Buonocore MH, Carmichael O, Jagust W, Weiner MW. Associations among vascular risk factors, carotid atherosclerosis, and cortical volume and thickness in older adults. Stroke. 2012 Nov; 43(11):2865-70. PMID: 22984010; PMCID: PMC3732460.
      123. Lo RY, Jagust W. Vascular burden and Alzheimer disease pathologic progression. Neurology. 2012 Sep 25; 79(13):1349-55. PMID: 22972646; PMCID: PMC3448744.
      124. Oh H, Habeck C, Madison C, Jagust W. Covarying alterations in Aß deposition, glucose metabolism, and gray matter volume in cognitively normal elderly. Hum Brain Mapp. 2014 Jan; 35(1):297-308. PMID: 22965806; PMCID: PMC3600112.
      125. Dang LC, O'Neil JP, Jagust W. Dopamine supports coupling of attention-related networks. J Neurosci. 2012 Jul 11; 32(28):9582-7. PMID: 22787044; PMCID: PMC3410707.
      126. Landau S, Jagust W. Physical Activity and AD-Related Pathology-Reply. Arch Neurol. 2012 Jul 01; 69(7):940-1. PMID: 23753644.
        View in: PubMed
      127. Dang LC, Donde A, Madison C, O'Neil JP, Jagust W. Striatal dopamine influences the default mode network to affect shifting between object features. J Cogn Neurosci. 2012 Sep; 24(9):1960-70. PMID: 22640392; PMCID: PMC3510672.
      128. Landau SM, Marks SM, Mormino EC, Rabinovici GD, Oh H, O'Neil JP, Wilson RS, Jagust W. Association of lifetime cognitive engagement and low ß-amyloid deposition. Arch Neurol. 2012 May; 69(5):623-29. PMID: 22271235; PMCID: PMC3747737.
      129. Lo RY, Jagust W. Predicting missing biomarker data in a longitudinal study of Alzheimer disease. Neurology. 2012 May 01; 78(18):1376-82. PMID: 22491869; PMCID: PMC3345787.
      130. Oh H, Madison C, Haight TJ, Markley C, Jagust W. Effects of age and ß-amyloid on cognitive changes in normal elderly people. Neurobiol Aging. 2012 Dec; 33(12):2746-55. PMID: 22429886; PMCID: PMC3381075.
      131. Swaminathan S, Shen L, Risacher SL, Yoder KK, West JD, Kim S, Nho K, Foroud T, Inlow M, Potkin SG, Huentelman MJ, Craig DW, Jagust W, Koeppe RA, Mathis CA, Jack CR, Weiner MW, Saykin AJ. Amyloid pathway-based candidate gene analysis of [(11)C]PiB-PET in the Alzheimer's Disease Neuroimaging Initiative (ADNI) cohort. Brain Imaging Behav. 2012 Mar; 6(1):1-15. PMID: 21901424; PMCID: PMC3256261.
      132. Caroli A, Prestia A, Chen K, Ayutyanont N, Landau SM, Madison CM, Haense C, Herholz K, Nobili F, Reiman EM, Jagust W, Frisoni GB. Summary metrics to assess Alzheimer disease-related hypometabolic pattern with 18F-FDG PET: head-to-head comparison. J Nucl Med. 2012 Apr; 53(4):592-600. PMID: 22343502; PMCID: PMC3640308.
      133. Bakken TE, Roddey JC, Djurovic S, Akshoomoff N, Amaral DG, Bloss CS, Casey BJ, Chang L, Ernst TM, Gruen JR, Jernigan TL, Kaufmann WE, Kenet T, Kennedy DN, Kuperman JM, Murray SS, Sowell ER, Rimol LM, Mattingsdal M, Melle I, Agartz I, Andreassen OA, Schork NJ, Dale AM. Association of common genetic variants in GPCPD1 with scaling of visual cortical surface area in humans. Proc Natl Acad Sci U S A. 2012 Mar 06; 109(10):3985-90. PMID: 22343285; PMCID: PMC3309762.
      134. Perrotin A, Mormino EC, Madison CM, Hayenga AO, Jagust W. Subjective cognition and amyloid deposition imaging: a Pittsburgh Compound B positron emission tomography study in normal elderly individuals. Arch Neurol. 2012 Feb; 69(2):223-9. PMID: 22332189; PMCID: PMC4004919.
      135. Villemagne VL, Klunk WE, Mathis CA, Rowe CC, Brooks DJ, Hyman BT, Ikonomovic MD, Ishii K, Jack CR, Jagust W, Johnson KA, Koeppe RA, Lowe VJ, Masters CL, Montine TJ, Morris JC, Nordberg A, Petersen RC, Reiman EM, Selkoe DJ, Sperling RA, Van Laere K, Weiner MW, Drzezga A. Aß Imaging: feasible, pertinent, and vital to progress in Alzheimer's disease. Eur J Nucl Med Mol Imaging. 2012 Feb; 39(2):209-19. PMID: 22218879; PMCID: PMC3261395.
      136. Mitchell JM, O'Neil JP, Janabi M, Marks SM, Jagust W, Fields HL. Alcohol consumption induces endogenous opioid release in the human orbitofrontal cortex and nucleus accumbens. Sci Transl Med. 2012 Jan 11; 4(116):116ra6. PMID: 22238334.
        View in: PubMed
      137. Cohen AD, Rabinovici GD, Mathis CA, Jagust W, Klunk WE, Ikonomovic MD. Using Pittsburgh Compound B for in vivo PET imaging of fibrillar amyloid-beta. Adv Pharmacol. 2012; 64:27-81. PMID: 22840744; PMCID: PMC3542972.
      138. Reiman EM, Jagust W. Brain imaging in the study of Alzheimer's disease. Neuroimage. 2012 Jun; 61(2):505-16. PMID: 22173295; PMCID: PMC3351556.
      139. Rabinovici GD, Rosen HJ, Alkalay A, Kornak J, Furst AJ, Agarwal N, Mormino EC, O'Neil JP, Janabi M, Karydas A, Growdon ME, Jang JY, Huang EJ, Dearmond SJ, Trojanowski JQ, Grinberg LT, Gorno-Tempini ML, Seeley WW, Miller BL, Jagust W. Amyloid vs FDG-PET in the differential diagnosis of AD and FTLD. Neurology. 2011 Dec 06; 77(23):2034-42. PMID: 22131541; PMCID: PMC3236517.
      140. Reed BR, Marchant NL, Jagust W, DeCarli CC, Mack W, Chui HC. Coronary risk correlates with cerebral amyloid deposition. Neurobiol Aging. 2012 Sep; 33(9):1979-87. PMID: 22078485; PMCID: PMC3371309.
      141. Weiner MW, Veitch DP, Aisen PS, Beckett LA, Cairns NJ, Green RC, Harvey D, Jack CR, Jagust W, Liu E, Morris JC, Petersen RC, Saykin AJ, Schmidt ME, Shaw L, Siuciak JA, Soares H, Toga AW, Trojanowski JQ. The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception. Alzheimers Dement. 2012 Feb; 8(1 Suppl):S1-68. PMID: 22047634; PMCID: PMC3329969.
      142. Marchant NL, Reed BR, DeCarli CS, Madison CM, Weiner MW, Chui HC, Jagust W. Cerebrovascular disease, ß-amyloid, and cognition in aging. Neurobiol Aging. 2012 May; 33(5):1006.e25-36. PMID: 22048124; PMCID: PMC3274647.
      143. Ewers M, Insel P, Jagust W, Shaw L, Trojanowski JQ, Aisen P, Petersen RC, Schuff N, Weiner MW. CSF biomarker and PIB-PET-derived beta-amyloid signature predicts metabolic, gray matter, and cognitive changes in nondemented subjects. Cereb Cortex. 2012 Sep; 22(9):1993-2004. PMID: 22038908; PMCID: PMC3500862.
      144. Jagust W, Mormino EC. Lifespan brain activity, ß-amyloid, and Alzheimer's disease. Trends Cogn Sci. 2011 Nov; 15(11):520-6. PMID: 21983147; PMCID: PMC3206968.
      145. Mormino EC, Brandel MG, Madison CM, Marks S, Baker SL, Jagust W. Aß Deposition in aging is associated with increases in brain activation during successful memory encoding. Cereb Cortex. 2012 Aug; 22(8):1813-23. PMID: 21945849; PMCID: PMC3388896.
      146. Chiang GC, Insel PS, Tosun D, Schuff N, Truran-Sacrey D, Raptentsetsang ST, Thompson PM, Reiman EM, Jack CR, Fox NC, Jagust W, Harvey DJ, Beckett LA, Gamst A, Aisen PS, Petersen RC, Weiner MW. Impact of apolipoprotein E4-cerebrospinal fluid ß-amyloid interaction on hippocampal volume loss over 1 year in mild cognitive impairment. Alzheimers Dement. 2011 Sep; 7(5):514-20. PMID: 21889115; PMCID: PMC3177162.
      147. Mormino EC, Brandel MG, Madison CM, Rabinovici GD, Marks S, Baker SL, Jagust W. Not quite PIB-positive, not quite PIB-negative: slight PIB elevations in elderly normal control subjects are biologically relevant. Neuroimage. 2012 Jan 16; 59(2):1152-60. PMID: 21884802; PMCID: PMC3230690.
      148. Toledo JB, Vanderstichele H, Figurski M, Aisen PS, Petersen RC, Weiner MW, Jack CR, Jagust W, Decarli C, Toga AW, Toledo E, Xie SX, Lee VM, Trojanowski JQ, Shaw LM. Factors affecting Aß plasma levels and their utility as biomarkers in ADNI. Acta Neuropathol. 2011 Oct; 122(4):401-13. PMID: 21805181; PMCID: PMC3299300.
      149. Jagust W. Amyloid imaging: liberal or conservative? Let the data decide. Arch Neurol. 2011 Nov; 68(11):1377-8. PMID: 21747005.
        View in: PubMed
      150. Lo RY, Hubbard AE, Shaw LM, Trojanowski JQ, Petersen RC, Aisen PS, Weiner MW, Jagust W. Longitudinal change of biomarkers in cognitive decline. Arch Neurol. 2011 Oct; 68(10):1257-66. PMID: 21670386.
        View in: PubMed
      151. Frisoni GB, Jagust W. Subcortical vascular dementia exists! Neurology. 2011 Jul 05; 77(1):12-3. PMID: 21593436.
        View in: PubMed
      152. Rosenbloom MH, Alkalay A, Agarwal N, Baker SL, O'Neil JP, Janabi M, Yen IV, Growdon M, Jang J, Madison C, Mormino EC, Rosen HJ, Gorno-Tempini ML, Weiner MW, Miller BL, Jagust W, Rabinovici GD. Distinct clinical and metabolic deficits in PCA and AD are not related to amyloid distribution. Neurology. 2011 May 24; 76(21):1789-96. PMID: 21525424; PMCID: PMC3100124.
      153. Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, Gamst A, Holtzman DM, Jagust W, Petersen RC, Snyder PJ, Carrillo MC, Thies B, Phelps CH. The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 2011 May; 7(3):270-9. PMID: 21514249; PMCID: PMC3312027.
      154. Klostermann EC, Braskie MN, Landau SM, O'Neil JP, Jagust W. Dopamine and frontostriatal networks in cognitive aging. Neurobiol Aging. 2012 Mar; 33(3):623.e15-24. PMID: 21511369; PMCID: PMC3245323.
      155. Tosun D, Schuff N, Mathis CA, Jagust W, Weiner MW. Spatial patterns of brain amyloid-beta burden and atrophy rate associations in mild cognitive impairment. Brain. 2011 Apr; 134(Pt 4):1077-88. PMID: 21429865; PMCID: PMC3069703.
      156. Mormino EC, Smiljic A, Hayenga AO, Onami SH, Greicius MD, Rabinovici GD, Janabi M, Baker SL, Yen IV, Madison CM, Miller BL, Jagust W. Relationships between ß-amyloid and functional connectivity in different components of the default mode network in aging. Cereb Cortex. 2011 Oct; 21(10):2399-407. PMID: 21383234.
        View in: PubMed
      157. Chen K, Ayutyanont N, Langbaum JB, Fleisher AS, Reschke C, Lee W, Liu X, Bandy D, Alexander GE, Thompson PM, Shaw L, Trojanowski JQ, Jack CR, Landau SM, Foster NL, Harvey DJ, Weiner MW, Koeppe RA, Jagust W, Reiman EM. Characterizing Alzheimer's disease using a hypometabolic convergence index. Neuroimage. 2011 May 01; 56(1):52-60. PMID: 21276856; PMCID: PMC3066300.
      158. Rostomian AH, Madison C, Rabinovici GD, Jagust W. Early 11C-PIB frames and 18F-FDG PET measures are comparable: a study validated in a cohort of AD and FTLD patients. J Nucl Med. 2011 Feb; 52(2):173-9. PMID: 21233181; PMCID: PMC3166243.
      159. Gabel MJ, Foster NL, Heidebrink JL, Higdon R, Aizenstein HJ, Arnold SE, Barbas NR, Boeve BF, Burke JR, Clark CM, Dekosky ST, Farlow MR, Jagust W, Kawas CH, Koeppe RA, Leverenz JB, Lipton AM, Peskind ER, Turner RS, Womack KB, Zamrini EY. Validation of consensus panel diagnosis in dementia. Arch Neurol. 2010 Dec; 67(12):1506-12. PMID: 21149812; PMCID: PMC3178413.
      160. Womack KB, Diaz-Arrastia R, Aizenstein HJ, Arnold SE, Barbas NR, Boeve BF, Clark CM, DeCarli CS, Jagust W, Leverenz JB, Peskind ER, Turner RS, Zamrini EY, Heidebrink JL, Burke JR, DeKosky ST, Farlow MR, Gabel MJ, Higdon R, Kawas CH, Koeppe RA, Lipton AM, Foster NL. Temporoparietal hypometabolism in frontotemporal lobar degeneration and associated imaging diagnostic errors. Arch Neurol. 2011 Mar; 68(3):329-37. PMID: 21059987; PMCID: PMC3058918.
      161. Oh H, Mormino EC, Madison C, Hayenga A, Smiljic A, Jagust W. ß-Amyloid affects frontal and posterior brain networks in normal aging. Neuroimage. 2011 Feb 01; 54(3):1887-95. PMID: 20965254; PMCID: PMC3038633.
      162. Jagust W. Amyloid imaging: coming to a PET scanner near you. Ann Neurol. 2010 Sep; 68(3):277-8. PMID: 20818786.
        View in: PubMed
      163. Wu X, Chen K, Yao L, Ayutyanont N, Langbaum JB, Fleisher A, Reschke C, Lee W, Liu X, Alexander GE, Bandy D, Foster NL, Thompson PM, Harvey DJ, Weiner MW, Koeppe RA, Jagust W, Reiman EM. Assessing the reliability to detect cerebral hypometabolism in probable Alzheimer's disease and amnestic mild cognitive impairment. J Neurosci Methods. 2010 Oct 15; 192(2):277-85. PMID: 20678521; PMCID: PMC2952503.
      164. Landau SM, Harvey D, Madison CM, Reiman EM, Foster NL, Aisen PS, Petersen RC, Shaw LM, Trojanowski JQ, Jack CR, Weiner MW, Jagust W. Comparing predictors of conversion and decline in mild cognitive impairment. Neurology. 2010 Jul 20; 75(3):230-8. PMID: 20592257; PMCID: PMC2906178.
      165. Braskie MN, Landau SM, Wilcox CE, Taylor SD, O'Neil JP, Baker SL, Madison CM, Jagust W. Correlations of striatal dopamine synthesis with default network deactivations during working memory in younger adults. Hum Brain Mapp. 2011 Jun; 32(6):947-61. PMID: 20578173; PMCID: PMC3176660.
      166. Apostolova LG, Hwang KS, Andrawis JP, Green AE, Babakchanian S, Morra JH, Cummings JL, Toga AW, Trojanowski JQ, Shaw LM, Jack CR, Petersen RC, Aisen PS, Jagust W, Koeppe RA, Mathis CA, Weiner MW, Thompson PM. 3D PIB and CSF biomarker associations with hippocampal atrophy in ADNI subjects. Neurobiol Aging. 2010 Aug; 31(8):1284-303. PMID: 20538372; PMCID: PMC3051831.
      167. Wilcox CE, Braskie MN, Kluth JT, Jagust W. Overeating Behavior and Striatal Dopamine with 6-[F]-Fluoro-L-m-Tyrosine PET. J Obes. 2010; 2010. PMID: 20798859; PMCID: PMC2925447.
      168. Weiner MW, Aisen PS, Jack CR, Jagust W, Trojanowski JQ, Shaw L, Saykin AJ, Morris JC, Cairns N, Beckett LA, Toga A, Green R, Walter S, Soares H, Snyder P, Siemers E, Potter W, Cole PE, Schmidt M. The Alzheimer's disease neuroimaging initiative: progress report and future plans. Alzheimers Dement. 2010 May; 6(3):202-11.e7. PMID: 20451868; PMCID: PMC2927112.
      169. Aisen PS, Petersen RC, Donohue MC, Gamst A, Raman R, Thomas RG, Walter S, Trojanowski JQ, Shaw LM, Beckett LA, Jack CR, Jagust W, Toga AW, Saykin AJ, Morris JC, Green RC, Weiner MW. Clinical Core of the Alzheimer's Disease Neuroimaging Initiative: progress and plans. Alzheimers Dement. 2010 May; 6(3):239-46. PMID: 20451872; PMCID: PMC2867843.
      170. Jagust W, Bandy D, Chen K, Foster NL, Landau SM, Mathis CA, Price JC, Reiman EM, Skovronsky D, Koeppe RA. The Alzheimer's Disease Neuroimaging Initiative positron emission tomography core. Alzheimers Dement. 2010 May; 6(3):221-9. PMID: 20451870; PMCID: PMC2920531.
      171. Trojanowski JQ, Vandeerstichele H, Korecka M, Clark CM, Aisen PS, Petersen RC, Blennow K, Soares H, Simon A, Lewczuk P, Dean R, Siemers E, Potter WZ, Weiner MW, Jack CR, Jagust W, Toga AW, Lee VM, Shaw LM. Update on the biomarker core of the Alzheimer's Disease Neuroimaging Initiative subjects. Alzheimers Dement. 2010 May; 6(3):230-8. PMID: 20451871; PMCID: PMC2867838.
      172. Furst AJ, Rabinovici GD, Rostomian AH, Steed T, Alkalay A, Racine C, Miller BL, Jagust W. Cognition, glucose metabolism and amyloid burden in Alzheimer's disease. Neurobiol Aging. 2012 Feb; 33(2):215-25. PMID: 20417582; PMCID: PMC2920373.
      173. Chen K, Langbaum JB, Fleisher AS, Ayutyanont N, Reschke C, Lee W, Liu X, Bandy D, Alexander GE, Thompson PM, Foster NL, Harvey DJ, de Leon MJ, Koeppe RA, Jagust W, Weiner MW, Reiman EM. Twelve-month metabolic declines in probable Alzheimer's disease and amnestic mild cognitive impairment assessed using an empirically pre-defined statistical region-of-interest: findings from the Alzheimer's Disease Neuroimaging Initiative. Neuroimage. 2010 Jun; 51(2):654-64. PMID: 20202480; PMCID: PMC2856742.
      174. Lavretsky H, Zheng L, Weiner MW, Mungas D, Reed B, Kramer JH, Jagust W, Chui H, Mack WJ. Association of depressed mood and mortality in older adults with and without cognitive impairment in a prospective naturalistic study. Am J Psychiatry. 2010 May; 167(5):589-97. PMID: 20160005; PMCID: PMC2864365.
      175. Rabinovici GD, Furst AJ, Alkalay A, Racine CA, O'Neil JP, Janabi M, Baker SL, Agarwal N, Bonasera SJ, Mormino EC, Weiner MW, Gorno-Tempini ML, Rosen HJ, Miller BL, Jagust W. Increased metabolic vulnerability in early-onset Alzheimer's disease is not related to amyloid burden. Brain. 2010 Feb; 133(Pt 2):512-28. PMID: 20080878; PMCID: PMC2858015.
      176. Jack CR, Knopman DS, Jagust W, Shaw LM, Aisen PS, Weiner MW, Petersen RC, Trojanowski JQ. Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurol. 2010 Jan; 9(1):119-28. PMID: 20083042; PMCID: PMC2819840.
      177. Kuczynski B, Targan E, Madison C, Weiner M, Zhang Y, Reed B, Chui HC, Jagust W. White matter integrity and cortical metabolic associations in aging and dementia. Alzheimers Dement. 2010 Jan; 6(1):54-62. PMID: 20129319; PMCID: PMC2817977.
      178. Petersen RC, Aisen PS, Beckett LA, Donohue MC, Gamst AC, Harvey DJ, Jack CR, Jagust W, Shaw LM, Toga AW, Trojanowski JQ, Weiner MW. Alzheimer's Disease Neuroimaging Initiative (ADNI): clinical characterization. Neurology. 2010 Jan 19; 74(3):201-9. PMID: 20042704; PMCID: PMC2809036.
      179. Schuff N, Matsumoto S, Kmiecik J, Studholme C, Du A, Ezekiel F, Miller BL, Kramer JH, Jagust W, Chui HC, Weiner MW. Cerebral blood flow in ischemic vascular dementia and Alzheimer's disease, measured by arterial spin-labeling magnetic resonance imaging. Alzheimers Dement. 2009 Nov; 5(6):454-62. PMID: 19896584; PMCID: PMC2802181.
      180. Christine CW, Starr PA, Larson PS, Eberling JL, Jagust W, Hawkins RA, VanBrocklin HF, Wright JF, Bankiewicz KS, Aminoff MJ. Safety and tolerability of putaminal AADC gene therapy for Parkinson disease. Neurology. 2009 Nov 17; 73(20):1662-9. PMID: 19828868; PMCID: PMC2839805.
      181. Jagust W, Landau SM, Shaw LM, Trojanowski JQ, Koeppe RA, Reiman EM, Foster NL, Petersen RC, Weiner MW, Price JC, Mathis CA. Relationships between biomarkers in aging and dementia. Neurology. 2009 Oct 13; 73(15):1193-9. PMID: 19822868; PMCID: PMC2764726.
      182. Haense C, Herholz K, Jagust W, Heiss WD. Performance of FDG PET for detection of Alzheimer's disease in two independent multicentre samples (NEST-DD and ADNI). Dement Geriatr Cogn Disord. 2009; 28(3):259-66. PMID: 19786778.
        View in: PubMed
      183. Jagust W. Genes and cognitive aging. Front Neurosci. 2009; 3(2):161-3. PMID: 20228865; PMCID: PMC2752315.
      184. Landau SM, Harvey D, Madison CM, Koeppe RA, Reiman EM, Foster NL, Weiner MW, Jagust W. Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCI. Neurobiol Aging. 2011 Jul; 32(7):1207-18. PMID: 19660834; PMCID: PMC2891865.
      185. Jagust W. Mapping brain beta-amyloid. Curr Opin Neurol. 2009 Aug; 22(4):356-61. PMID: 19478666; PMCID: PMC2882160.
      186. Jagust W. Amyloid + activation = Alzheimer's? Neuron. 2009 Jul 30; 63(2):141-3. PMID: 19640471.
        View in: PubMed
      187. Barnes DE, Yaffe K, Belfor N, Jagust W, DeCarli C, Reed BR, Kramer JH. Computer-based cognitive training for mild cognitive impairment: results from a pilot randomized, controlled trial. Alzheimer Dis Assoc Disord. 2009 Jul-Sep; 23(3):205-10. PMID: 19812460; PMCID: PMC2760033.
      188. Kuczynski B, Jagust W, Chui HC, Reed B. An inverse association of cardiovascular risk and frontal lobe glucose metabolism. Neurology. 2009 Feb 24; 72(8):738-43. PMID: 19237703; PMCID: PMC2677543.
      189. Cools R, Frank MJ, Gibbs SE, Miyakawa A, Jagust W, D'Esposito M. Striatal dopamine predicts outcome-specific reversal learning and its sensitivity to dopaminergic drug administration. J Neurosci. 2009 Feb 04; 29(5):1538-43. PMID: 19193900; PMCID: PMC2940719.
      190. Langbaum JB, Chen K, Lee W, Reschke C, Bandy D, Fleisher AS, Alexander GE, Foster NL, Weiner MW, Koeppe RA, Jagust W, Reiman EM. Categorical and correlational analyses of baseline fluorodeoxyglucose positron emission tomography images from the Alzheimer's Disease Neuroimaging Initiative (ADNI). Neuroimage. 2009 May 01; 45(4):1107-16. PMID: 19349228; PMCID: PMC2886795.
      191. Van Boven RW, Harrington GS, Hackney DB, Ebel A, Gauger G, Bremner JD, D'Esposito M, Detre JA, Haacke EM, Jack CR, Jagust W, Le Bihan D, Mathis CA, Mueller S, Mukherjee P, Schuff N, Chen A, Weiner MW. Advances in neuroimaging of traumatic brain injury and posttraumatic stress disorder. J Rehabil Res Dev. 2009; 46(6):717-57. PMID: 20104401; PMCID: PMC3233771.
      192. Rabinovici GD, Jagust W. Amyloid imaging in aging and dementia: testing the amyloid hypothesis in vivo. Behav Neurol. 2009; 21(1):117-28. PMID: 19847050; PMCID: PMC2804478.
      193. Braskie MN, Wilcox CE, Landau SM, O'Neil JP, Baker SL, Madison CM, Kluth JT, Jagust W. Relationship of striatal dopamine synthesis capacity to age and cognition. J Neurosci. 2008 Dec 24; 28(52):14320-8. PMID: 19109513; PMCID: PMC2880923.
      194. Mormino EC, Kluth JT, Madison CM, Rabinovici GD, Baker SL, Miller BL, Koeppe RA, Mathis CA, Weiner MW, Jagust W. Episodic memory loss is related to hippocampal-mediated beta-amyloid deposition in elderly subjects. Brain. 2009 May; 132(Pt 5):1310-23. PMID: 19042931; PMCID: PMC2677792.
      195. Rabinovici GD, Jagust W, Furst AJ, Ogar JM, Racine CA, Mormino EC, O'Neil JP, Lal RA, Dronkers NF, Miller BL, Gorno-Tempini ML. Abeta amyloid and glucose metabolism in three variants of primary progressive aphasia. Ann Neurol. 2008 Oct; 64(4):388-401. PMID: 18991338; PMCID: PMC2648510.
      196. DeCarli C, Reed BR, Jagust W, Martinez O, Ortega M, Mungas D. Brain behavior relationships among African Americans, whites, and Hispanics. Alzheimer Dis Assoc Disord. 2008 Oct-Dec; 22(4):382-91. PMID: 19068502; PMCID: PMC2743876.
      197. Lavretsky H, Zheng L, Weiner MW, Mungas D, Reed B, Kramer JH, Jagust W, Chui H, Mack WJ. The MRI brain correlates of depressed mood, anhedonia, apathy, and anergia in older adults with and without cognitive impairment or dementia. Int J Geriatr Psychiatry. 2008 Oct; 23(10):1040-50. PMID: 18412291; PMCID: PMC2575050.
      198. Farias ST, Mungas D, Reed BR, Cahn-Weiner D, Jagust W, Baynes K, Decarli C. The measurement of everyday cognition (ECog): scale development and psychometric properties. Neuropsychology. 2008 Jul; 22(4):531-44. PMID: 18590364; PMCID: PMC2877034.
      199. Landau SM, Lal R, O'Neil JP, Baker S, Jagust W. Striatal dopamine and working memory. Cereb Cortex. 2009 Feb; 19(2):445-54. PMID: 18550595; PMCID: PMC2733326.
      200. Kuczynski B, Reed B, Mungas D, Weiner M, Chui HC, Jagust W. Cognitive and anatomic contributions of metabolic decline in Alzheimer disease and cerebrovascular disease. Arch Neurol. 2008 May; 65(5):650-5. PMID: 18474742; PMCID: PMC2556212.
      201. Garrod MG, Green R, Allen LH, Mungas DM, Jagust W, Haan MN, Miller JW. Fraction of total plasma vitamin B12 bound to transcobalamin correlates with cognitive function in elderly Latinos with depressive symptoms. Clin Chem. 2008 Jul; 54(7):1210-7. PMID: 18451312; PMCID: PMC2752269.
      202. Eberling JL, Jagust W, Christine CW, Starr P, Larson P, Bankiewicz KS, Aminoff MJ. Results from a phase I safety trial of hAADC gene therapy for Parkinson disease. Neurology. 2008 May 20; 70(21):1980-3. PMID: 18401019.
        View in: PubMed
      203. Eberling JL, Bankiewicz KS, O'Neil JP, Jagust W. PET 6-[F]fluoro-L-m-tyrosine Studies of Dopaminergic Function in Human and Nonhuman Primates. Front Hum Neurosci. 2007; 1:9. PMID: 18958223; PMCID: PMC2525990.
      204. Jagust W. Is amnestic mild cognitive impairment always AD? Neurology. 2008 Feb 12; 70(7):502-3. PMID: 18268243.
        View in: PubMed
      205. Cools R, Gibbs SE, Miyakawa A, Jagust W, D'Esposito M. Working memory capacity predicts dopamine synthesis capacity in the human striatum. J Neurosci. 2008 Jan 30; 28(5):1208-12. PMID: 18234898.
        View in: PubMed
      206. Jagust W, Zheng L, Harvey DJ, Mack WJ, Vinters HV, Weiner MW, Ellis WG, Zarow C, Mungas D, Reed BR, Kramer JH, Schuff N, DeCarli C, Chui HC. Neuropathological basis of magnetic resonance images in aging and dementia. Ann Neurol. 2008 Jan; 63(1):72-80. PMID: 18157909; PMCID: PMC2624571.
      207. Jagust W, Reed B, Mungas D, Ellis W, Decarli C. What does fluorodeoxyglucose PET imaging add to a clinical diagnosis of dementia? Neurology. 2007 Aug 28; 69(9):871-7. PMID: 17724289.
        View in: PubMed
      208. Foster NL, Heidebrink JL, Clark CM, Jagust W, Arnold SE, Barbas NR, DeCarli CS, Turner RS, Koeppe RA, Higdon R, Minoshima S. FDG-PET improves accuracy in distinguishing frontotemporal dementia and Alzheimer's disease. Brain. 2007 Oct; 130(Pt 10):2616-35. PMID: 17704526.
        View in: PubMed
      209. Boxer AL, Rabinovici GD, Kepe V, Goldman J, Furst AJ, Huang SC, Baker SL, O'neil JP, Chui H, Geschwind MD, Small GW, Barrio JR, Jagust W, Miller BL. Amyloid imaging in distinguishing atypical prion disease from Alzheimer disease. Neurology. 2007 Jul 17; 69(3):283-90. PMID: 17636066.
        View in: PubMed
      210. Haan MN, Aiello AE, West NA, Jagust W. C-reactive protein and rate of dementia in carriers and non carriers of Apolipoprotein APOE4 genotype. Neurobiol Aging. 2008 Dec; 29(12):1774-82. PMID: 17540481; PMCID: PMC2593150.
      211. Rabinovici GD, Furst AJ, O'Neil JP, Racine CA, Mormino EC, Baker SL, Chetty S, Patel P, Pagliaro TA, Klunk WE, Mathis CA, Rosen HJ, Miller BL, Jagust W. 11C-PIB PET imaging in Alzheimer disease and frontotemporal lobar degeneration. Neurology. 2007 Apr 10; 68(15):1205-12. PMID: 17420404.
        View in: PubMed
      212. Jagust W. What can imaging reveal about obesity and the brain? Curr Alzheimer Res. 2007 Apr; 4(2):135-9. PMID: 17430236.
        View in: PubMed
      213. Haan MN, Miller JW, Aiello AE, Whitmer RA, Jagust W, Mungas DM, Allen LH, Green R. Homocysteine, B vitamins, and the incidence of dementia and cognitive impairment: results from the Sacramento Area Latino Study on Aging. Am J Clin Nutr. 2007 Feb; 85(2):511-7. PMID: 17284751; PMCID: PMC1892349.
      214. Reed BR, Mungas DM, Kramer JH, Ellis W, Vinters HV, Zarow C, Jagust W, Chui HC. Profiles of neuropsychological impairment in autopsy-defined Alzheimer's disease and cerebrovascular disease. Brain. 2007 Mar; 130(Pt 3):731-9. PMID: 17267522.
        View in: PubMed
      215. Zhang Y, Schuff N, Jahng GH, Bayne W, Mori S, Schad L, Mueller S, Du AT, Kramer JH, Yaffe K, Chui H, Jagust W, Miller BL, Weiner MW. Diffusion tensor imaging of cingulum fibers in mild cognitive impairment and Alzheimer disease. Neurology. 2007 Jan 02; 68(1):13-9. PMID: 17200485; PMCID: PMC1941719.
      216. Chui HC, Zarow C, Mack WJ, Ellis WG, Zheng L, Jagust W, Mungas D, Reed BR, Kramer JH, Decarli CC, Weiner MW, Vinters HV. Cognitive impact of subcortical vascular and Alzheimer's disease pathology. Ann Neurol. 2006 Dec; 60(6):677-87. PMID: 17192928; PMCID: PMC1851933.
      217. Sun FT, Schriber RA, Greenia JM, He J, Gitcho A, Jagust W. Automated template-based PET region of interest analyses in the aging brain. Neuroimage. 2007 Jan 15; 34(2):608-17. PMID: 17112749; PMCID: PMC1828371.
      218. Aiello AE, Haan M, Blythe L, Moore K, Gonzalez JM, Jagust W. The influence of latent viral infection on rate of cognitive decline over 4 years. J Am Geriatr Soc. 2006 Jul; 54(7):1046-54. PMID: 16866674.
        View in: PubMed
      219. Zhu X, Schuff N, Kornak J, Soher B, Yaffe K, Kramer JH, Ezekiel F, Miller BL, Jagust W, Weiner MW. Effects of Alzheimer disease on fronto-parietal brain N-acetyl aspartate and myo-inositol using magnetic resonance spectroscopic imaging. Alzheimer Dis Assoc Disord. 2006 Apr-Jun; 20(2):77-85. PMID: 16772742; PMCID: PMC1820860.
      220. Jagust W, Gitcho A, Sun F, Kuczynski B, Mungas D, Haan M. Brain imaging evidence of preclinical Alzheimer's disease in normal aging. Ann Neurol. 2006 Apr; 59(4):673-81. PMID: 16470518.
        View in: PubMed
      221. Nordahl CW, Ranganath C, Yonelinas AP, Decarli C, Fletcher E, Jagust W. White matter changes compromise prefrontal cortex function in healthy elderly individuals. J Cogn Neurosci. 2006 Mar; 18(3):418-29. PMID: 16513006; PMCID: PMC3776596.
      222. Jagust W. Positron emission tomography and magnetic resonance imaging in the diagnosis and prediction of dementia. Alzheimers Dement. 2006 Jan; 2(1):36-42. PMID: 19595854.
        View in: PubMed
      223. Kishiyama MM, Yonelinas AP, Kroll NE, Lazzara MM, Nolan EC, Jones EG, Jagust W. Bilateral thalamic lesions affect recollection- and familiarity-based recognition memory judgments. Cortex. 2005 Dec; 41(6):778-88. PMID: 16353367.
        View in: PubMed
      224. Ramos MI, Allen LH, Mungas DM, Jagust W, Haan MN, Green R, Miller JW. Low folate status is associated with impaired cognitive function and dementia in the Sacramento Area Latino Study on Aging. Am J Clin Nutr. 2005 Dec; 82(6):1346-52. PMID: 16332669.
        View in: PubMed
      225. Mueller SG, Weiner MW, Thal LJ, Petersen RC, Jack C, Jagust W, Trojanowski JQ, Toga AW, Beckett L. The Alzheimer's disease neuroimaging initiative. Neuroimaging Clin N Am. 2005 Nov; 15(4):869-77, xi-xii. PMID: 16443497; PMCID: PMC2376747.
      226. Jagust W, Harvey D, Mungas D, Haan M. Central obesity and the aging brain. Arch Neurol. 2005 Oct; 62(10):1545-8. PMID: 16216937.
        View in: PubMed
      227. Farias ST, Mungas D, Jagust W. Degree of discrepancy between self and other-reported everyday functioning by cognitive status: dementia, mild cognitive impairment, and healthy elders. Int J Geriatr Psychiatry. 2005 Sep; 20(9):827-34. PMID: 16116577; PMCID: PMC2872134.
      228. Mungas D, Harvey D, Reed BR, Jagust W, DeCarli C, Beckett L, Mack WJ, Kramer JH, Weiner MW, Schuff N, Chui HC. Longitudinal volumetric MRI change and rate of cognitive decline. Neurology. 2005 Aug 23; 65(4):565-71. PMID: 16116117; PMCID: PMC1820871.
      229. Lopez OL, Becker JT, Jagust W, Fitzpatrick A, Carlson MC, DeKosky ST, Breitner J, Lyketsos CG, Jones B, Kawas C, Kuller LH. Neuropsychological characteristics of mild cognitive impairment subgroups. J Neurol Neurosurg Psychiatry. 2006 Feb; 77(2):159-65. PMID: 16103044; PMCID: PMC2077558.
      230. Rascovsky K, Salmon DP, Lipton AM, Leverenz JB, DeCarli C, Jagust W, Clark CM, Mendez MF, Tang-Wai DF, Graff-Radford NR, Galasko D. Rate of progression differs in frontotemporal dementia and Alzheimer disease. Neurology. 2005 Aug 09; 65(3):397-403. PMID: 16087904.
        View in: PubMed
      231. Newman AB, Fitzpatrick AL, Lopez O, Jackson S, Lyketsos C, Jagust W, Ives D, Dekosky ST, Kuller LH. Dementia and Alzheimer's disease incidence in relationship to cardiovascular disease in the Cardiovascular Health Study cohort. J Am Geriatr Soc. 2005 Jul; 53(7):1101-7. PMID: 16108925.
        View in: PubMed
      232. Mueller SG, Weiner MW, Thal LJ, Petersen RC, Jack CR, Jagust W, Trojanowski JQ, Toga AW, Beckett L. Ways toward an early diagnosis in Alzheimer's disease: the Alzheimer's Disease Neuroimaging Initiative (ADNI). Alzheimers Dement. 2005 Jul; 1(1):55-66. PMID: 17476317.
        View in: PubMed
      233. Du AT, Schuff N, Chao LL, Kornak J, Jagust W, Kramer JH, Reed BR, Miller BL, Norman D, Chui HC, Weiner MW. Age effects on atrophy rates of entorhinal cortex and hippocampus. Neurobiol Aging. 2006 May; 27(5):733-40. PMID: 15961190; PMCID: PMC1779763.
      234. Lopez OL, Kuller LH, Becker JT, Jagust W, DeKosky ST, Fitzpatrick A, Breitner J, Lyketsos C, Kawas C, Carlson M. Classification of vascular dementia in the Cardiovascular Health Study Cognition Study. Neurology. 2005 May 10; 64(9):1539-47. PMID: 15883314.
        View in: PubMed
      235. Kuller LH, Lopez OL, Jagust W, Becker JT, DeKosky ST, Lyketsos C, Kawas C, Breitner JC, Fitzpatrick A, Dulberg C. Determinants of vascular dementia in the Cardiovascular Health Cognition Study. Neurology. 2005 May 10; 64(9):1548-52. PMID: 15883315; PMCID: PMC3378359.
      236. Du AT, Schuff N, Chao LL, Kornak J, Ezekiel F, Jagust W, Kramer JH, Reed BR, Miller BL, Norman D, Chui HC, Weiner MW. White matter lesions are associated with cortical atrophy more than entorhinal and hippocampal atrophy. Neurobiol Aging. 2005 Apr; 26(4):553-9. PMID: 15653183.
        View in: PubMed
      237. Johnson NA, Jahng GH, Weiner MW, Miller BL, Chui HC, Jagust W, Gorno-Tempini ML, Schuff N. Pattern of cerebral hypoperfusion in Alzheimer disease and mild cognitive impairment measured with arterial spin-labeling MR imaging: initial experience. Radiology. 2005 Mar; 234(3):851-9. PMID: 15734937; PMCID: PMC1851934.
      238. Nordahl CW, Ranganath C, Yonelinas AP, DeCarli C, Reed BR, Jagust W. Different mechanisms of episodic memory failure in mild cognitive impairment. Neuropsychologia. 2005; 43(11):1688-97. PMID: 16009250; PMCID: PMC3771323.
      239. Chao LL, Schuff N, Kramer JH, Du AT, Capizzano AA, O'Neill J, Wolkowitz OM, Jagust W, Chui HC, Miller BL, Yaffe K, Weiner MW. Reduced medial temporal lobe N-acetylaspartate in cognitively impaired but nondemented patients. Neurology. 2005 Jan 25; 64(2):282-9. PMID: 15668426; PMCID: PMC1851679.
      240. Campbell AK, Jagust W, Mungas DM, Miller JW, Green R, Haan MN, Allen LH. Low erythrocyte folate, but not plasma vitamin B-12 or homocysteine,is associated with dementia in elderly Latinos. J Nutr Health Aging. 2005; 9(1):39-43. PMID: 15750664.
        View in: PubMed
      241. Jagust W. Dementia: finding the signals in the noise. Lancet Neurol. 2005 Jan; 4(1):10-1. PMID: 15620851.
        View in: PubMed
      242. Fitzpatrick AL, Kuller LH, Lopez OL, Kawas CH, Jagust W. Survival following dementia onset: Alzheimer's disease and vascular dementia. J Neurol Sci. 2005 Mar 15; 229-230:43-9. PMID: 15760618.
        View in: PubMed
      243. DeCarli C, Fletcher E, Ramey V, Harvey D, Jagust W. Anatomical mapping of white matter hyperintensities (WMH): exploring the relationships between periventricular WMH, deep WMH, and total WMH burden. Stroke. 2005 Jan; 36(1):50-5. PMID: 15576652; PMCID: PMC3816357.
      244. Reed BR, Eberling JL, Mungas D, Weiner M, Kramer JH, Jagust W. Effects of white matter lesions and lacunes on cortical function. Arch Neurol. 2004 Oct; 61(10):1545-50. PMID: 15477508.
        View in: PubMed
      245. Ezekiel F, Chao L, Kornak J, Du AT, Cardenas V, Truran D, Jagust W, Chui H, Miller B, Yaffe K, Schuff N, Weiner M. Comparisons between global and focal brain atrophy rates in normal aging and Alzheimer disease: Boundary Shift Integral versus tracing of the entorhinal cortex and hippocampus. Alzheimer Dis Assoc Disord. 2004 Oct-Dec; 18(4):196-201. PMID: 15592130; PMCID: PMC1820853.
      246. Tullberg M, Fletcher E, DeCarli C, Mungas D, Reed BR, Harvey DJ, Weiner MW, Chui HC, Jagust W. White matter lesions impair frontal lobe function regardless of their location. Neurology. 2004 Jul 27; 63(2):246-53. PMID: 15277616; PMCID: PMC1893004.
      247. DeCarli C, Mungas D, Harvey D, Reed B, Weiner M, Chui H, Jagust W. Memory impairment, but not cerebrovascular disease, predicts progression of MCI to dementia. Neurology. 2004 Jul 27; 63(2):220-7. PMID: 15277612; PMCID: PMC1820872.
      248. Kramer JH, Schuff N, Reed BR, Mungas D, Du AT, Rosen HJ, Jagust W, Miller BL, Weiner MW, Chui HC. Hippocampal volume and retention in Alzheimer's disease. J Int Neuropsychol Soc. 2004 Jul; 10(4):639-43. PMID: 15327742.
        View in: PubMed
      249. Petkov CI, Wu CC, Eberling JL, Mungas D, Zrelak PA, Yonelinas AP, Haan MN, Jagust W. Correlates of memory function in community-dwelling elderly: the importance of white matter hyperintensities. J Int Neuropsychol Soc. 2004 May; 10(3):371-81. PMID: 15147595.
        View in: PubMed
      250. Farias ST, Mungas D, Reed B, Haan MN, Jagust W. Everyday functioning in relation to cognitive functioning and neuroimaging in community-dwelling Hispanic and non-Hispanic older adults. J Int Neuropsychol Soc. 2004 May; 10(3):342-54. PMID: 15147592; PMCID: PMC2872145.
      251. Jagust W. Molecular neuroimaging in Alzheimer's disease. NeuroRx. 2004 Apr; 1(2):206-12. PMID: 15717021.
        View in: PubMed
      252. Maltz JS, Eberling JL, Jagust W, Budinger TF. Enhanced cutaneous vascular response in AD subjects under donepezil therapy. Neurobiol Aging. 2004 Apr; 25(4):475-81. PMID: 15013568.
        View in: PubMed
      253. Jagust W. The proteomics of positron emission tomography. Ann Neurol. 2004 Mar; 55(3):303-5. PMID: 14991807.
        View in: PubMed
      254. Du AT, Schuff N, Kramer JH, Ganzer S, Zhu XP, Jagust W, Miller BL, Reed BR, Mungas D, Yaffe K, Chui HC, Weiner MW. Higher atrophy rate of entorhinal cortex than hippocampus in AD. Neurology. 2004 Feb 10; 62(3):422-7. PMID: 14872024; PMCID: PMC1820859.
      255. Fitzpatrick AL, Kuller LH, Ives DG, Lopez OL, Jagust W, Breitner JC, Jones B, Lyketsos C, Dulberg C. Incidence and prevalence of dementia in the Cardiovascular Health Study. J Am Geriatr Soc. 2004 Feb; 52(2):195-204. PMID: 14728627.
        View in: PubMed
      256. Reed BR, Mungas DM, Kramer JH, Betz BP, Ellis W, Vinters HV, Zarow C, Jagust W, Chui HC. Clinical and neuropsychological features in autopsy-defined vascular dementia. Clin Neuropsychol. 2004 Feb; 18(1):63-74. PMID: 15595359.
        View in: PubMed
      257. Higdon R, Foster NL, Koeppe RA, DeCarli CS, Jagust W, Clark CM, Barbas NR, Arnold SE, Turner RS, Heidebrink JL, Minoshima S. A comparison of classification methods for differentiating fronto-temporal dementia from Alzheimer's disease using FDG-PET imaging. Stat Med. 2004 Jan 30; 23(2):315-26. PMID: 14716732.
        View in: PubMed
      258. Eberling JL, Wu C, Tong-Turnbeaugh R, Jagust W. Estrogen- and tamoxifen-associated effects on brain structure and function. Neuroimage. 2004 Jan; 21(1):364-71. PMID: 14741674.
        View in: PubMed
      259. Lopez OL, Jagust W, DeKosky ST, Becker JT, Fitzpatrick A, Dulberg C, Breitner J, Lyketsos C, Jones B, Kawas C, Carlson M, Kuller LH. Prevalence and classification of mild cognitive impairment in the Cardiovascular Health Study Cognition Study: part 1. Arch Neurol. 2003 Oct; 60(10):1385-9. PMID: 14568808.
        View in: PubMed
      260. Lopez OL, Jagust W, Dulberg C, Becker JT, DeKosky ST, Fitzpatrick A, Breitner J, Lyketsos C, Jones B, Kawas C, Carlson M, Kuller LH. Risk factors for mild cognitive impairment in the Cardiovascular Health Study Cognition Study: part 2. Arch Neurol. 2003 Oct; 60(10):1394-9. PMID: 14568809.
        View in: PubMed
      261. Miller JW, Green R, Ramos MI, Allen LH, Mungas DM, Jagust W, Haan MN. Homocysteine and cognitive function in the Sacramento Area Latino Study on Aging. Am J Clin Nutr. 2003 Sep; 78(3):441-7. PMID: 12936927.
        View in: PubMed
      262. Eberling JL, Wu C, Haan MN, Mungas D, Buonocore M, Jagust W. Preliminary evidence that estrogen protects against age-related hippocampal atrophy. Neurobiol Aging. 2003 Sep; 24(5):725-32. PMID: 12885580.
        View in: PubMed
      263. Schuff N, Capizzano AA, Du AT, Amend DL, O'Neill J, Norman D, Jagust W, Chui HC, Kramer JH, Reed BR, Miller BL, Yaffe K, Weiner MW. Different patterns of N-acetylaspartate loss in subcortical ischemic vascular dementia and AD. Neurology. 2003 Aug 12; 61(3):358-64. PMID: 12913198; PMCID: PMC1820863.
      264. Cardenas VA, Du AT, Hardin D, Ezekiel F, Weber P, Jagust W, Chui HC, Schuff N, Weiner MW. Comparison of methods for measuring longitudinal brain change in cognitive impairment and dementia. Neurobiol Aging. 2003 Jul-Aug; 24(4):537-44. PMID: 12714110.
        View in: PubMed
      265. Aisen PS, Egelko S, Andrews H, Diaz-Arrastia R, Weiner M, DeCarli C, Jagust W, Miller JW, Green R, Bell K, Sano M. A pilot study of vitamins to lower plasma homocysteine levels in Alzheimer disease. Am J Geriatr Psychiatry. 2003 Mar-Apr; 11(2):246-9. PMID: 12611755.
        View in: PubMed
      266. Du AT, Schuff N, Zhu XP, Jagust W, Miller BL, Reed BR, Kramer JH, Mungas D, Yaffe K, Chui HC, Weiner MW. Atrophy rates of entorhinal cortex in AD and normal aging. Neurology. 2003 Feb 11; 60(3):481-6. PMID: 12578931; PMCID: PMC1851672.
      267. Haan MN, Mungas DM, Gonzalez HM, Ortiz TA, Acharya A, Jagust W. Prevalence of dementia in older latinos: the influence of type 2 diabetes mellitus, stroke and genetic factors. J Am Geriatr Soc. 2003 Feb; 51(2):169-77. PMID: 12558712.
        View in: PubMed
      268. Wu CC, Mungas D, Eberling JL, Reed BR, Jagust W. Imaging Interactions between Alzheimer's disease and cerebrovascular disease. Ann N Y Acad Sci. 2002 Nov; 977:403-10. PMID: 12480779.
        View in: PubMed
      269. Mungas D, Reed BR, Jagust W, DeCarli C, Mack WJ, Kramer JH, Weiner MW, Schuff N, Chui HC. Volumetric MRI predicts rate of cognitive decline related to AD and cerebrovascular disease. Neurology. 2002 Sep 24; 59(6):867-73. PMID: 12297568; PMCID: PMC1820873.
      270. Jagust W, Eberling JL, Wu CC, Finkbeiner A, Mungas D, Valk PE, Haan MN. Brain function and cognition in a community sample of elderly Latinos. Neurology. 2002 Aug 13; 59(3):378-83. PMID: 12177371.
        View in: PubMed
      271. Wu CC, Mungas D, Petkov CI, Eberling JL, Zrelak PA, Buonocore MH, Brunberg JA, Haan MN, Jagust W. Brain structure and cognition in a community sample of elderly Latinos. Neurology. 2002 Aug 13; 59(3):383-91. PMID: 12177372.
        View in: PubMed
      272. Rosen HJ, Hartikainen KM, Jagust W, Kramer JH, Reed BR, Cummings JL, Boone K, Ellis W, Miller C, Miller BL. Utility of clinical criteria in differentiating frontotemporal lobar degeneration (FTLD) from AD. Neurology. 2002 Jun 11; 58(11):1608-15. PMID: 12058087.
        View in: PubMed
      273. Du AT, Schuff N, Laakso MP, Zhu XP, Jagust W, Yaffe K, Kramer JH, Miller BL, Reed BR, Norman D, Chui HC, Weiner MW. Effects of subcortical ischemic vascular dementia and AD on entorhinal cortex and hippocampus. Neurology. 2002 Jun 11; 58(11):1635-41. PMID: 12058091; PMCID: PMC1820858.
      274. Miller JW, Green R, Mungas DM, Reed BR, Jagust W. Homocysteine, vitamin B6, and vascular disease in AD patients. Neurology. 2002 May 28; 58(10):1471-5. PMID: 12034781.
        View in: PubMed
      275. Hsu YY, Schuff N, Amend DL, Du AT, Norman D, Chui HC, Jagust W, Weiner MW. Quantitative magnetic resonance imaging differences between Alzheimer disease with and without subcortical lacunes. Alzheimer Dis Assoc Disord. 2002 Apr-Jun; 16(2):58-64. PMID: 12040300; PMCID: PMC1820852.
      276. Haan MN, Jagust W, Galasko D, Kaye J. Effect of extrapyramidal signs and Lewy bodies on survival in patients with Alzheimer disease. Arch Neurol. 2002 Apr; 59(4):588-93. PMID: 11939893.
        View in: PubMed
      277. Schuff N, Capizzano AA, Du AT, Amend DL, O'Neill J, Norman D, Kramer J, Jagust W, Miller B, Wolkowitz OM, Yaffe K, Weiner MW. Selective reduction of N-acetylaspartate in medial temporal and parietal lobes in AD. Neurology. 2002 Mar 26; 58(6):928-35. PMID: 11914410; PMCID: PMC1851674.
      278. Quinn J, Moore M, Benson DF, Clark CM, Doody R, Jagust W, Knopman D, Kaye JA. A videotaped CIBIC for dementia patients: validity and reliability in a simulated clinical trial. Neurology. 2002 Feb 12; 58(3):433-7. PMID: 11839844.
        View in: PubMed
      279. Mungas D, Jagust W, Reed BR, Kramer JH, Weiner MW, Schuff N, Norman D, Mack WJ, Willis L, Chui HC. MRI predictors of cognition in subcortical ischemic vascular disease and Alzheimer's disease. Neurology. 2001 Dec 26; 57(12):2229-35. PMID: 11756602; PMCID: PMC1862483.
      280. Braver TS, Barch DM, Keys BA, Carter CS, Cohen JD, Kaye JA, Janowsky JS, Taylor SF, Yesavage JA, Mumenthaler MS, Jagust W, Reed BR. Context processing in older adults: evidence for a theory relating cognitive control to neurobiology in healthy aging. J Exp Psychol Gen. 2001 Dec; 130(4):746-63. PMID: 11757878.
        View in: PubMed
      281. Jagust W. Untangling vascular dementia. Lancet. 2001 Dec 22-29; 358(9299):2097-8. PMID: 11784618.
        View in: PubMed
      282. Silverman DH, Small GW, Chang CY, Lu CS, Kung De Aburto MA, Chen W, Czernin J, Rapoport SI, Pietrini P, Alexander GE, Schapiro MB, Jagust W, Hoffman JM, Welsh-Bohmer KA, Alavi A, Clark CM, Salmon E, de Leon MJ, Mielke R, Cummings JL, Kowell AP, Gambhir SS, Hoh CK, Phelps ME. Positron emission tomography in evaluation of dementia: Regional brain metabolism and long-term outcome. JAMA. 2001 Nov 07; 286(17):2120-7. PMID: 11694153.
        View in: PubMed
      283. Du AT, Schuff N, Amend D, Laakso MP, Hsu YY, Jagust W, Yaffe K, Kramer JH, Reed B, Norman D, Chui HC, Weiner MW. Magnetic resonance imaging of the entorhinal cortex and hippocampus in mild cognitive impairment and Alzheimer's disease. J Neurol Neurosurg Psychiatry. 2001 Oct; 71(4):441-7. PMID: 11561025; PMCID: PMC1763497.
      284. Mungas D, Reed BR, Ellis WG, Jagust W. The effects of age on rate of progression of Alzheimer disease and dementia with associated cerebrovascular disease. Arch Neurol. 2001 Aug; 58(8):1243-7. PMID: 11493164.
        View in: PubMed
      285. Jagust W, Thisted R, Devous MD, Van Heertum R, Mayberg H, Jobst K, Smith AD, Borys N. SPECT perfusion imaging in the diagnosis of Alzheimer's disease: a clinical-pathologic study. Neurology. 2001 Apr 10; 56(7):950-6. PMID: 11294935.
        View in: PubMed
      286. Reed BR, Eberling JL, Mungas D, Weiner M, Jagust W. Frontal lobe hypometabolism predicts cognitive decline in patients with lacunar infarcts. Arch Neurol. 2001 Mar; 58(3):493-7. PMID: 11255455.
        View in: PubMed
      287. Fein G, Di Sclafani V, Tanabe J, Cardenas V, Weiner MW, Jagust W, Reed BR, Norman D, Schuff N, Kusdra L, Greenfield T, Chui H. Hippocampal and cortical atrophy predict dementia in subcortical ischemic vascular disease. Neurology. 2000 Dec 12; 55(11):1626-35. PMID: 11113215; PMCID: PMC2733356.
      288. Jagust W. Neuroimaging in dementia. Neurol Clin. 2000 Nov; 18(4):885-902. PMID: 11072266.
        View in: PubMed
      289. Vinters HV, Ellis WG, Zarow C, Zaias BW, Jagust W, Mack WJ, Chui HC. Neuropathologic substrates of ischemic vascular dementia. J Neuropathol Exp Neurol. 2000 Nov; 59(11):931-45. PMID: 11089571.
        View in: PubMed
      290. Eberling JL, Reed BR, Coleman JE, Jagust W. Effect of estrogen on cerebral glucose metabolism in postmenopausal women. Neurology. 2000 Sep 26; 55(6):875-7. PMID: 10994014.
        View in: PubMed
      291. Reed BR, Eberling JL, Mungas D, Weiner MW, Jagust W. Memory failure has different mechanisms in subcortical stroke and Alzheimer's disease. Ann Neurol. 2000 Sep; 48(3):275-84. PMID: 10976633; PMCID: PMC1899248.
      292. Bankiewicz KS, Eberling JL, Kohutnicka M, Jagust W, Pivirotto P, Bringas J, Cunningham J, Budinger TF, Harvey-White J. Convection-enhanced delivery of AAV vector in parkinsonian monkeys; in vivo detection of gene expression and restoration of dopaminergic function using pro-drug approach. Exp Neurol. 2000 Jul; 164(1):2-14. PMID: 10877910.
        View in: PubMed
      293. Capizzano AA, Schuff N, Amend DL, Tanabe JL, Norman D, Maudsley AA, Jagust W, Chui HC, Fein G, Segal MR, Weiner MW. Subcortical ischemic vascular dementia: assessment with quantitative MR imaging and 1H MR spectroscopy. AJNR Am J Neuroradiol. 2000 Apr; 21(4):621-30. PMID: 10782769; PMCID: PMC1945115.
      294. Jagust W, Noseworthy JH. Brain atrophy as a surrogate marker in MS: faster, simpler, better? Neurology. 2000 Feb 22; 54(4):782-3. PMID: 10690960.
        View in: PubMed
      295. O'Neill J, Eberling JL, Schuff N, Jagust W, Reed B, Soto G, Ezekiel F, Klein G, Weiner MW. Method to correlate 1H MRSI and 18FDG-PET. Magn Reson Med. 2000 Feb; 43(2):244-50. PMID: 10680688.
        View in: PubMed
      296. Chui HC, Mack W, Jackson JE, Mungas D, Reed BR, Tinklenberg J, Chang FL, Skinner K, Tasaki C, Jagust W. Clinical criteria for the diagnosis of vascular dementia: a multicenter study of comparability and interrater reliability. Arch Neurol. 2000 Feb; 57(2):191-6. PMID: 10681076.
        View in: PubMed
      297. Haan MN, Shemanski L, Jagust W, Manolio TA, Kuller L. The role of APOE epsilon4 in modulating effects of other risk factors for cognitive decline in elderly persons. JAMA. 1999 Jul 07; 282(1):40-6. PMID: 10404910.
        View in: PubMed
      298. Kwan LT, Reed BR, Eberling JL, Schuff N, Tanabe J, Norman D, Weiner MW, Jagust W. Effects of subcortical cerebral infarction on cortical glucose metabolism and cognitive function. Arch Neurol. 1999 Jul; 56(7):809-14. PMID: 10404982; PMCID: PMC2733358.
      299. Eberling JL, Bankiewicz KS, Pivirotto P, Bringas J, Chen K, Nowotnik DP, Steiner JP, Budinger TF, Jagust W. Dopamine transporter loss and clinical changes in MPTP-lesioned primates. Brain Res. 1999 Jun 19; 832(1-2):184-7. PMID: 10375668.
        View in: PubMed
      300. Tanabe JL, Ezekiel F, Jagust W, Reed BR, Norman D, Schuff N, Weiner MW, Chui H, Fein G. Magnetization transfer ratio of white matter hyperintensities in subcortical ischemic vascular dementia. AJNR Am J Neuroradiol. 1999 May; 20(5):839-44. PMID: 10369354; PMCID: PMC1892905.
      301. Reed W, Jagust W, Al-Mateen M, Vichinsky E. Role of positron emission tomography in determining the extent of CNS ischemia in patients with sickle cell disease. Am J Hematol. 1999 Apr; 60(4):268-72. PMID: 10203099.
        View in: PubMed
      302. Reed BR, Jagust W. Opening a window on cerebral cholinergic function: PET imaging of acetylcholinesterase. Neurology. 1999 Mar 10; 52(4):680-2. PMID: 10078708.
        View in: PubMed
      303. Jagust W, Haan MN, Reed BR, Eberling JL. Brain perfusion imaging predicts survival in Alzheimer's disease. Neurology. 1998 Oct; 51(4):1009-13. PMID: 9781521.
        View in: PubMed
      304. Eberling JL, Jagust W, Taylor S, Bringas J, Pivirotto P, VanBrocklin HF, Bankiewicz KS. A novel MPTP primate model of Parkinson's disease: neurochemical and clinical changes. Brain Res. 1998 Sep 14; 805(1-2):259-62. PMID: 9733979.
        View in: PubMed
      305. Jordan S, Bankiewicz KS, Eberling JL, VanBrocklin HF, O'Neil JP, Jagust W. An in vivo microdialysis study of striatal 6-[18F]fluoro-L-m-tyrosine metabolism. Neurochem Res. 1998 Apr; 23(4):513-7. PMID: 9566585.
        View in: PubMed
      306. Schuff N, Amend D, Ezekiel F, Steinman SK, Tanabe J, Norman D, Jagust W, Kramer JH, Mastrianni JA, Fein G, Weiner MW. Changes of hippocampal N-acetyl aspartate and volume in Alzheimer's disease. A proton MR spectroscopic imaging and MRI study. Neurology. 1997 Dec; 49(6):1513-21. PMID: 9409338.
        View in: PubMed
      307. Lafosse JM, Reed BR, Mungas D, Sterling SB, Wahbeh H, Jagust W. Fluency and memory differences between ischemic vascular dementia and Alzheimer's disease. Neuropsychology. 1997 Oct; 11(4):514-22. PMID: 9345695.
        View in: PubMed
      308. Jagust W, Eberling JL, Reed BR, Mathis CA, Budinger TF. Clinical studies of cerebral blood flow in Alzheimer's disease. Ann N Y Acad Sci. 1997 Sep 26; 826:254-62. PMID: 9329697.
        View in: PubMed
      309. Eberling JL, Bankiewicz KS, Jordan S, VanBrocklin HF, Jagust W. PET studies of functional compensation in a primate model of Parkinson's disease. Neuroreport. 1997 Aug 18; 8(12):2727-33. PMID: 9295108.
        View in: PubMed
      310. Tanabe JL, Ezekiel F, Jagust W, Schuff N, Fein G. Volumetric method for evaluating magnetization transfer ratio of tissue categories: application to areas of white matter signal hyperintensity in the elderly. Radiology. 1997 Aug; 204(2):570-5. PMID: 9240555.
        View in: PubMed
      311. Klein GJ, Teng X, Jagust W, Eberling JL, Acharya A, Reutter BW, Huesman RH. A methodology for specifying PET VOI's using multimodality techniques. IEEE Trans Med Imaging. 1997 Aug; 16(4):405-15. PMID: 9262998.
        View in: PubMed
      312. Eberling JL, Roberts JA, Rapp PR, Tuszynski MH, Jagust W. Cerebral glucose metabolism and memory in aged rhesus macaques. Neurobiol Aging. 1997 Jul-Aug; 18(4):437-43. PMID: 9330976.
        View in: PubMed
      313. Murphy GM, Sullivan EV, Gallagher-Thompson D, Thompson LW, van Duijn CM, Forno LS, Ellis WG, Jagust W, Yesavage J, Tinklenberg JR. No association between the alpha 1-antichymotrypsin A allele and Alzheimer's disease. Neurology. 1997 May; 48(5):1313-6. PMID: 9153464.
        View in: PubMed
      314. Jordan S, Eberling JL, Bankiewicz KS, Rosenberg D, Coxson PG, VanBrocklin HF, O'Neil JP, Emborg ME, Jagust W. 6-[18F]fluoro-L-m-tyrosine: metabolism, positron emission tomography kinetics, and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine lesions in primates. Brain Res. 1997 Mar 07; 750(1-2):264-76. PMID: 9098552.
        View in: PubMed
      315. Paller KA, Acharya A, Richardson BC, Plaisant O, Shimamura AP, Reed BR, Jagust W. Functional Neuroimaging of Cortical Dysfunction in Alcoholic Korsakoff's Syndrome. J Cogn Neurosci. 1997 Mar; 9(2):277-93. PMID: 23962017.
        View in: PubMed
      316. Nordahl TE, Kusubov N, Carter C, Salamat S, Cummings AM, O'Shora-Celaya L, Eberling J, Robertson L, Huesman RH, Jagust W, Budinger TF. Temporal lobe metabolic differences in medication-free outpatients with schizophrenia via the PET-600. Neuropsychopharmacology. 1996 Dec; 15(6):541-54. PMID: 8946428.
        View in: PubMed
      317. Jagust W, Haan MN, Eberling JL, Wolfe N, Reed BR. Functional imaging predicts cognitive decline in Alzheimer's disease. J Neuroimaging. 1996 Jul; 6(3):156-60. PMID: 8704290.
        View in: PubMed
      318. Jagust W, Eberling JL, Biegon A, Taylor SE, VanBrocklin HF, Jordan S, Hanrahan SM, Roberts JA, Brennan KM, Mathis CA. Iodine-123-5-iodo-6-nitroquipazine: SPECT radiotracer to image the serotonin transporter. J Nucl Med. 1996 Jul; 37(7):1207-14. PMID: 8965200.
        View in: PubMed
      319. Jagust W. Functional imaging patterns in Alzheimer's disease. Relationships to neurobiology. Ann N Y Acad Sci. 1996 Jan 17; 777:30-6. PMID: 8624103.
        View in: PubMed
      320. Jagust W. Dementia--an update. West J Med. 1995 Nov; 163(5):473-4. PMID: 8533415; PMCID: PMC1303177.
      321. Eberling JL, Roberts JA, De Manincor DJ, Brennan KM, Hanrahan SM, Vanbrocklin HF, Roos MS, Jagust W. PET studies of cerebral glucose metabolism in conscious rhesus macaques. Neurobiol Aging. 1995 Sep-Oct; 16(5):825-32. PMID: 8532117.
        View in: PubMed
      322. Jagust W, Johnson KA, Holman BL. SPECT perfusion imaging in the diagnosis of dementia. J Neuroimaging. 1995 Jul; 5 Suppl 1:S45-52. PMID: 7626837.
        View in: PubMed
      323. Eberling JL, Nordahl TE, Kusubov N, Reed BR, Budinger TF, Jagust W. Reduced temporal lobe glucose metabolism in aging. J Neuroimaging. 1995 Jul; 5(3):178-82. PMID: 7626826.
        View in: PubMed
      324. Wolfe N, Reed BR, Eberling JL, Jagust W. Temporal lobe perfusion on single photon emission computed tomography predicts the rate of cognitive decline in Alzheimer's disease. Arch Neurol. 1995 Mar; 52(3):257-62. PMID: 7872878.
        View in: PubMed
      325. Kwo-On-Yuen PF, Newmark RD, Budinger TF, Kaye JA, Ball MJ, Jagust W. Brain N-acetyl-L-aspartic acid in Alzheimer's disease: a proton magnetic resonance spectroscopy study. Brain Res. 1994 Dec 26; 667(2):167-74. PMID: 7697354.
        View in: PubMed
      326. Jagust W. Functional imaging in dementia: an overview. J Clin Psychiatry. 1994 Nov; 55 Suppl:5-11. PMID: 7989292.
        View in: PubMed
      327. Biegon A, Eberling JL, Richardson BC, Roos MS, Wong ST, Reed BR, Jagust W. Human corpus callosum in aging and Alzheimer's disease: a magnetic resonance imaging study. Neurobiol Aging. 1994 Jul-Aug; 15(4):393-7. PMID: 7969715.
        View in: PubMed
      328. Eberling JL, Richardson BC, Reed BR, Wolfe N, Jagust W. Cortical glucose metabolism in Parkinson's disease without dementia. Neurobiol Aging. 1994 May-Jun; 15(3):329-35. PMID: 7936057.
        View in: PubMed
      329. Jagust W, Eberling JL, Richardson BC, Reed BR, Baker MG, Nordahl TE, Budinger TF. The cortical topography of temporal lobe hypometabolism in early Alzheimer's disease. Brain Res. 1993 Dec 03; 629(2):189-98. PMID: 8111623.
        View in: PubMed
      330. Jagust W, Eberling JL, Roberts JA, Brennan KM, Hanrahan SM, VanBrocklin H, Enas JD, Biegon A, Mathis CA. In vivo imaging of the 5-hydroxytryptamine reuptake site in primate brain using single photon emission computed tomography and [123I]5-iodo-6-nitroquipazine. Eur J Pharmacol. 1993 Sep 28; 242(2):189-93. PMID: 8253114.
        View in: PubMed
      331. Biegon A, Mathis CA, Hanrahan SM, Jagust W. [125I]5-iodo-6-nitroquipazine: a potent and selective ligand for the 5-hydroxytryptamine uptake complex. II. In vivo studies in rats. Brain Res. 1993 Aug 13; 619(1-2):236-46. PMID: 8374782.
        View in: PubMed
      332. Eberling JL, Reed BR, Baker MG, Jagust W. Cognitive correlates of regional cerebral blood flow in Alzheimer's disease. Arch Neurol. 1993 Jul; 50(7):761-6. PMID: 8323482.
        View in: PubMed
      333. Friedland RP, Koss E, Lerner A, Hedera P, Ellis W, Dronkers N, Ober BA, Jagust W. Functional imaging, the frontal lobes, and dementia. Dementia. 1993 May-Aug; 4(3-4):192-203. PMID: 8401792.
        View in: PubMed
      334. Reed BR, Jagust W, Coulter L. Anosognosia in Alzheimer's disease: relationships to depression, cognitive function, and cerebral perfusion. J Clin Exp Neuropsychol. 1993 Mar; 15(2):231-44. PMID: 8491848.
        View in: PubMed
      335. Martin EM, Robertson LC, Sorensen DJ, Jagust W, Mallon KF, Chirurgi VA. Speed of memory scanning is not affected in early HIV-1 infection. J Clin Exp Neuropsychol. 1993 Mar; 15(2):311-20. PMID: 8491853.
        View in: PubMed
      336. Martin EM, Robertson LC, Edelstein HE, Jagust W, Sorensen DJ, San Giovanni D, Chirurgi VA. Performance of patients with early HIV-1 infection on the Stroop Task. J Clin Exp Neuropsychol. 1992 Sep; 14(5):857-68. PMID: 1474150.
        View in: PubMed
      337. Eberling JL, Jagust W, Reed BR, Baker MG. Reduced temporal lobe blood flow in Alzheimer's disease. Neurobiol Aging. 1992 Jul-Aug; 13(4):483-91. PMID: 1508299.
        View in: PubMed
      338. Mathis CA, Bishop JE, Gerdes JM, Whitney JM, Brennan KM, Jagust W. Synthesis and evaluation of high affinity, aryl-substituted [18F]fluoropropylbenzamides for dopamine D-2 receptor studies. Int J Rad Appl Instrum B. 1992 Jul; 19(5):571-88. PMID: 1399687.
        View in: PubMed
      339. Jagust W, Reed BR, Martin EM, Eberling JL, Nelson-Abbott RA. Cognitive function and regional cerebral blood flow in Parkinson's disease. Brain. 1992 Apr; 115 ( Pt 2):521-37. PMID: 1606480.
        View in: PubMed
      340. Chui HC, Victoroff JI, Margolin D, Jagust W, Shankle R, Katzman R. Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers. Neurology. 1992 Mar; 42(3 Pt 1):473-80. PMID: 1549205.
        View in: PubMed
      341. Jagust W, Budinger TF. New neuroimaging techniques for investigating of brain-behavior relationships. NIDA Res Monogr. 1992; 124:95-115. PMID: 1470217.
        View in: PubMed
      342. Ober BA, Shenaut GK, Jagust W, Stillman RC. Automatic semantic priming with various category relations in Alzheimer's disease and normal aging. Psychol Aging. 1991 Dec; 6(4):647-60. PMID: 1777154.
        View in: PubMed
      343. Ober BA, Jagust W, Koss E, Delis DC, Friedland RP. Visuoconstructive performance and regional cerebral glucose metabolism in Alzheimer's disease. J Clin Exp Neuropsychol. 1991 Sep; 13(5):752-72. PMID: 1955530.
        View in: PubMed
      344. Jagust W, Seab JP, Huesman RH, Valk PE, Mathis CA, Reed BR, Coxson PG, Budinger TF. Diminished glucose transport in Alzheimer's disease: dynamic PET studies. J Cereb Blood Flow Metab. 1991 Mar; 11(2):323-30. PMID: 1997504.
        View in: PubMed
      345. Jagust W, Eberling JL. MRI, CT, SPECT, PET: their use in diagnosing dementia. Geriatrics. 1991 Feb; 46(2):28-35. PMID: 1991619.
        View in: PubMed
      346. Budinger TF, Derenzo SE, Huesman RH, Jagust W, Valk PE. High resolution positron emission tomography for medical science studies. Acta Radiol Suppl. 1991; 376:15-23. PMID: 1666758.
        View in: PubMed
      347. Valk PE, Jagust W, Derenzo SE, Huesman RH, Geyer AB, Budinger TF. Clinical evaluation of a high-resolution (2.6-mm) positron emission tomography. Radiology. 1990 Sep; 176(3):783-90. PMID: 2389037.
        View in: PubMed
      348. Jagust W, Reed BR, Seab JP, Budinger TF. Alzheimer's disease. Age at onset and single-photon emission computed tomographic patterns of regional cerebral blood flow. Arch Neurol. 1990 Jun; 47(6):628-33. PMID: 2346388.
        View in: PubMed
      349. Jagust W, Davies P, Tiller-Borcich JK, Reed BR. Focal Alzheimer's disease. Neurology. 1990 Jan; 40(1):14-9. PMID: 2296360.
        View in: PubMed
      350. Reed BR, Jagust W, Seab JP. Mental status as a predictor of daily function in progressive dementia. Gerontologist. 1989 Dec; 29(6):804-7. PMID: 2516001.
        View in: PubMed
      351. Reed BR, Jagust W, Seab JP, Ober BA. Memory and regional cerebral blood flow in mildly symptomatic Alzheimer's disease. Neurology. 1989 Nov; 39(11):1537-9. PMID: 2812339.
        View in: PubMed
      352. Friedland RP, Jagust W, Huesman RH, Koss E, Knittel B, Mathis CA, Ober BA, Mazoyer BM, Budinger TF. Regional cerebral glucose transport and utilization in Alzheimer's disease. Neurology. 1989 Nov; 39(11):1427-34. PMID: 2812318.
        View in: PubMed
      353. Jagust W, Reed BR, Seab JP, Kramer JH, Budinger TF. Clinical-physiologic correlates of Alzheimer's disease and frontal lobe dementia. Am J Physiol Imaging. 1989; 4(3):89-96. PMID: 2789844.
        View in: PubMed
      354. Seab JP, Jagust W, Wong ST, Roos MS, Reed BR, Budinger TF. Quantitative NMR measurements of hippocampal atrophy in Alzheimer's disease. Magn Reson Med. 1988 Oct; 8(2):200-8. PMID: 3210957.
        View in: PubMed
      355. Jagust W, Friedland RP, Budinger TF, Koss E, Ober B. Longitudinal studies of regional cerebral metabolism in Alzheimer's disease. Neurology. 1988 Jun; 38(6):909-12. PMID: 3259296.
        View in: PubMed
      356. Jagust W, Budinger TF, Reed BR. The diagnosis of dementia with single photon emission computed tomography. Arch Neurol. 1987 Mar; 44(3):258-62. PMID: 3493756.
        View in: PubMed
      357. Jagust W, Budinger TF, Huesman RH, Friedland RP, Mazoyer BM, Knittel BL. Methodologic factors affecting PET measurements of cerebral glucose metabolism. J Nucl Med. 1986 Aug; 27(8):1358-61. PMID: 3488379.
        View in: PubMed
      358. Jagust W, Friedland RP, Budinger TF. Positron emission tomography with [18F]fluorodeoxyglucose differentiates normal pressure hydrocephalus from Alzheimer-type dementia. J Neurol Neurosurg Psychiatry. 1985 Nov; 48(11):1091-6. PMID: 3878390; PMCID: PMC1028566.
      359. Koss E, Friedland RP, Ober BA, Jagust W. Differences in lateral hemispheric asymmetries of glucose utilization between early- and late-onset Alzheimer-type dementia. Am J Psychiatry. 1985 May; 142(5):638-40. PMID: 3872604.
        View in: PubMed
      360. Friedland RP, Budinger TF, Brant-Zawadzki M, Jagust W. The diagnosis of Alzheimer-type dementia. A preliminary comparison of positron emission tomography and proton magnetic resonance. JAMA. 1984 Nov 16; 252(19):2750-2. PMID: 6333523.
        View in: PubMed
      361. Friedland RP, Prusiner SB, Jagust W, Budinger TF, Davis RL. Bitemporal hypometabolism in Creutzfeldt-Jakob disease measured by positron emission tomography with [18F]-2-fluorodeoxyglucose. J Comput Assist Tomogr. 1984 Oct; 8(5):978-81. PMID: 6381559.
        View in: PubMed

      A U.S. Department of Energy National Laboratory Managed by the University of California

      This site is running Profiles RNS version v2.10.1-414-g6fb82b0a.